Author Index For Volume 46 - COnnecting REpositories · Barker CV See Julian BA et al 1397...

Author Index For Volume 46

AAbarca A (abst) 580Abboud HE See Choudhuiy GG et a! 37Abella E (abst) 571Abensur H (abst) 1746Abrahamson DR (abst) 1469AbrahAo SB (abst) 1740Abramowicz D, Pradier 0, De Pauw L, Kinnaert P, Mat

0, Surquin M, Doutrelepont J-M, Vanherweghem J-L,Cape! P, Vereerstraeten P, Goldman M: High-doseglucocorticosteroids increase the procoagulant effectsof OKT3 1596

Abrass CK, Spicer D, Raugi GJ: Insulin induces achange in extracellular matrix g!ycoproteinssynthesized by rat mesangial cells in culture 613

Abu-Kishk RA See Noble AR et al 1588Ackermann M See Kramer BK et al 1577Acuña G (abst) 587, 587Adam WR (abst) 931, 932Ader J-L (abst) 1246Admiraa! PJJ (abst) 1460Alkir A (abst) 569Agar J (abst) 940Aglibut S (abst) 931, 937Aguado S (abst) 582Aguilar Peña D (abst) 583Aguilar Peña M (abst) 560, 584Aguilera G, Kapur S, Feuil!an P, Sunar-Akbasak B,

Bathia AJ: Developmental changes in angiotensin IIreceptor subtypes and AT1 receptor mRNA in ratkidney 973

Ahn KY See Mohaupt MG et a! 653Ajzen H (abst). 1738, 1741, 1741, 1741, 1747, 1748, 1748, 1749,

1750, 1751, 1751, 1753, 1753Akram M (abst) 925Al Sabadani B See Gris J-C et a! 807Alamo C (abst) 556, 562, 562, 576, 576AlbarracIn C (abst) 561, 563Albarus MH (abst) 1746Albert E (abst) 573Alcázar JM (abst) 562Alcorn D See Rong P et a! 1583Alcorn D See Zhuo J et al 1483Alcoy E (abst) 573Aldred GP (abst) 934Alemán Romero C (abst) 584Alexander S (abst) 940Aljama P (abst) 563, 575, 576, 581Allen BJ (abst) 940Almirall J (abst) 573, 574Alonso JC (abst) 579, 580, 580, 580Alonso MC (abst) 575Alpers CE See Johnson RJ et a! 1255Alpers CE See Johnson RJ et al 1700Alsina J (abst) 557, 558, 572, 573, 584Alvarado JA See Bobadilla NA et a! 773Alvarez J (abst) 554, 554Alvarez M (abst) 576

Alvarez-Grande J (abst) 555, 582Alvarez-Lara MA (abst) 575Alvariño J (abst) 580, 580, 581Alves FR (abst) 1747Alves G (abst) 1739Alves MAVFR (abst) 1749Alves PR (abst) 1740Alvestrand A See Gutierrez A et a! 814Amar M (abst) 1739, 1753Amato M See Aterini S et al 461Amenabar JJ (abst) 583Amenós AM (abst) 555Aminian A (abst) 932Amling M, Grote HJ, Vogel M, Hahn M, Delling G:

Three-dimensional analysis of the spine in autopsycases with renal osteodystrophy 733

Amodeo C (abst) 1739Anaya F (abst) 579, 579, 579Anderson S See Simons JL et al 396Anderson SS, Kim Y, Tsilibaiy EC: Effects of matrix

glycation on mesangial cell adhesion, spreading andproliferation 1359

Ando T See Okuda S et al 1635Andrade LCF (abst) 1745Andreoli SP, Mallett C, Williams K, McAteer JA,

Roth!ein R, Doerschuk CM: Mechanisms ofpolymorphonuclear leukocyte mediated peritonealmesothelial cell injury 1100

Andrés A (abst) 556, 562Andrés E (abst) 572, 573, 580, 580, 581Andriolo A (abst) 1744Andüjar Sanchez M (abst) 583, 584Ang KS See Simon P et a! 1192Antunes MT (abst) 1750Aparicio M (abst) 1243, 1243Aparicio M See Combe C et a! 1381Apostolopoulos J (abst) 942Apostolopoulos JA (abst) 927, 934Ara JM (abst) 566Aranda JL (abst) 562, 576Aranda RA (abst) 1746Arap S (abst) 1743, 1745Araque A (abst) 556, 562, 562, 562, 576, 576Arbouw F (abst) 1468Archer SL See Shultz PJ et al 683Ardaillou N See Zhao J et a! 717Ardaillou R See Chatziantoniou C et a! 1570Ardaillou R See Zhao J et a! 717Arendshorst WJ See Chatziantoniou C et al 1570Argov S See Douvdevani A et a! 993Arisz I (abst) 1467Arisz L (abst) 1471Arisz L See Imholz ALT et al 333Armada E (abst) 566Armada Rodriguez E (abst) 566Armengol J (abst) 575

1765

1766 Author Index VoL 46

Armstrong A, Cunningham J: The treatment ofmetabolic bone disease in patients on peritonealdialysis 47:S-51

Arnaiz P (abst) 560Arranz M (abst) 570, 570, 570Arrizabalaga P (abst) 574Asano Y See Itoh Y et al 46:S-38Asensio C (abst) 583, 584Asensio M (abst) 570Assambo-Kieli C (abst) 1247, 1247Assmann KJM (abst) 1461, 1462, 1467Aterini S, Ippolito E, Salvadori M, Pacini S, Ruggiero

M, Ainato M: Second messenger formation altered bydifferent dialysis membranes in human leukocytes 461

Athaide HP (abst) 1738Atkins RC (abst) 922, 923, 926, 927, 929, 933Aucouturier P See Preud'homme J-L et al 965Audrain MAP See Esnault VLM et al 153Augeri C See Cannella G et al 1124Aurrekoetxea B (abst) 583Austin H See Soucie JM et al 893Autuly V See Simon P et al 1192Avis L (abst) 933Ayass W (abst) 940Ayo SH See Kreisberg ii et al 105Ayo SH See Kreisberg JI et al 1019Azevedo LS (abst) 1743, 1744, 1751

BBaamonde E (abst) 582Baboolal K, Meyer TW: The effect of acute angiotensin

II blocade on renal function in rats with reduced renalmass 980

Bachmann S See Schafer K et al 134Bader M See Schafer K et al 134Badr KF See Katoh T et al 341Badre L See Zhao J et al 717Baelde HJ See Bergijk EC et al 1663Baelde JJ (abst) 1462Baeza J (abst) 560Baggio B See Gambaro G et al 797Bailey RR (abst) . . . 921, 924, 924, 925, 925, 928, 928, 930, 934Bain RP See Hebert LA et al 1688Baines AD: Strategies and criteria for developing new

urinalysis tests 46:S-137Baines AD See Guder WG et al 46:S-1Bakker WW (abst) 1462, 1469, 1471Bakris G See Gaber L et al 161Baiazs N (abst) 929Balfe JW See Daneman D et al 1154Baliellas C (abst) 572Balla T See Hunyady L et al 1496Ballanti P See Cannella G et al 1124Ballantine DM See Klemm SA et al 1591Bailer JFW (abst) 1471Ballester M (abst) 585Ballieux BEPB (abst) 1462Bandeira MF (abst) 1752Bandler N (abst) 933Bannister KM (abst) 940Baquey A (abst) 1243Barajas L, Liu L, Tucker M: Localization of connexin43

in rat kidney 621Barbosa D (abst) 1738BarcelO P (abst) 582

Bardhan S See Kambayashi Y et al 1502Bardos P (abst) 1242Barendregt JNM See Florijn KW et a! 252Barim EM (abst) 1746Barker CV See Julian BA et al 1397Barkworth E See Shehata M et al 726Barnes P (abst) 921Barra ABL (abst) 1751Barrera JM (abst) 573Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P:

Differences in hormonal and renal vascular responsesbetween normotensive patients with autosomaldominant polycystic kidney disease and unaffectedfamily members 1118

Barretti P (abst) 1738, 1746Barrientos A See Herrero IA et al 1167Barril 0 (abst) 557, 562, 565Barros KR (abst) 1752Bartolome J (abst) 564, 565, 579, 579Bathia A.J See Aguilera G et al 973Batista JC (abst) 1750Baud L See Boutard V et al 1280Baxter YC (abst) 1744Beaujean V (abst) 1246Becker G (abst) 922, 929, 930, 943Beekhuis H (abst) 1472Belin TR See Goodman WG et al 1160Bell GM See Yaqoob M et a! 46:S-101Bellazzi R See Maggi E et al 869Bellini C See Fern C et al 780Bellomo G See Maggi E et al 869Bemelman FJ (abst) 1465, 1468Bemelman FJ, Buysmann S, Surachno J, Wilmink JM,

Schellekens PTA, ten Berge IJM: Pretreatment withdivided doses of steroids strongly decreases side effectsof OKT3 1674

Benasco C (abst) 572Bendini JC (abst) 1245Benedict JF See Pankewycz OG et a! 748Beneyto I (abst) 585, 585, 585Benito J (abst) 567, 567Berden JHM (abst) 1460Berdud I (abst) 563Bergamaschi C (abst) 1741

Bergijk EC (abst) 1462, 1469Bergijk EC, Baelde HJ, de Heer E, Bruijn JA:

Prevention of glomeruloscierosis by early cyclosporinetreatment of experimental lupus nephritis 1663

Bergstrom J See Gutierrez A et al 814Bergstrom J See HeimbUrger 0 et al 47:S-39Berka JL See Rong P et al 1583Bermejo M (abst) 555, 555Bernaert P See Lameire N et al 47:S-31Bernal MC (abst) 556, 556, 569, 569, 569Bernard A (abst) 1245Bernard A See Fels LM et al 46:S-81Bernard AM, Thielemans NO, Lauwerys RR: Urinary

protein 1 or Clara cell protein: A new sensitive markerof proximal tubular dysfunction 46:S-34

Bernard D (abst) 577Bernard-Pomier G (abst) 1245Berndt MC (abst) 942Berndt MC See Tipping PG et al 79Bernis C (abst) 561, 562, 565Bertram JF (abst) 931

Author Index: Vol. 46 1767

Besada E (abst) 567Beukhof JR (abst) 1470Bézian JH (abst) 1243Bianchi C See Tan M-S et a! 690Bianco AC (abst) 1743Bidani AK See Griffin KA et al 1010Biechy M (abst) 583, 584Bijieveld C (abst) 1463

Billington T (abst) 921Bib HJG (abst) 1471Bindels RJM (abst) 1459Bindels RJM See Rose UM et a! 223Birchall IE (abst) 932Bird SD (abst) 935Birmelé B (abst) 1242Birmingham DJ See Cosio FG et a! 986Biswas P See Choudhury GG et at 37Biurrun A (abst) 561Black T See Catanzaro DF et at 1513Boadle RA (abst) 925, 937Bobadilla NA, Tapia E, Franco M, Lopez P, Mendoza S,

GarcIa-Torres R, Alvarado JA, Herrera-Acosta J:Role of nitric oxide in renal hemodynamicabnormalities of cyclosporin nephrotoxicity 773

Bobbio SA (abst) 1742, 1751Boege F, Merkie M, Werle E, RUcide H: Structural

features related to the nephropathogenicity of Bence-Jones proteins 46:S-93

BoerP(abst) 1470Boer P See Rabelink TJ et a! 376Boer WH See Hené RJ et at 1694Boes A (abst) 1462Boeschoten EW See Krediet RT et at 47:S-7

Bogman MJJT (abst) 1462Bognar B See Kurz P et al 855Boim MA (abst) 1741, 1748Bolton WK See Pankewycz OG et at 748Bomhard EM, Falkenberg FW, Loof 1: Changes in

urinary enzymes and kidney-derived antigens afteracute renal papillary necrosis in rats 46:S-60

Bompart G (abst) 1245Bonal J (abst) 571, 582Bonet J (abst) 558, 559, 582Bono M (abst) 574, 574Bonucci E See Cannetla G et at 1124Boretli A (abst) 1744Borrego F (abst) 566, 575Borrego J (abst) 563, 576, 581Borrellas X (abst) 563, 564, 564, 565, 579, 579Borsatti A See Gambaro G et al 797Bosch E (abst) 565, 565Bosch JP See Ronco C et at 47:S-18Bosque CE (abst) 571Bosque E (abst) 572Botella J (abst) 567, 569Bottini PV (abst) 1739, 1749Bourke A (abst) 942Boutard V, Fouqueray B, Philippe C, Perez J, Baud L:

Fish oil supplementation and essential fatty aciddeficiency reduce nitric oxide synthesis by ratmacrophages 1280

Bover J, Jara A, Trinidad P, Rodriguez M, Martin-MatoA, Felsenfeld AJ: The catcemic response to PTH inthe rat: Effect of elevated PTH levels and uremia 310

Bowman P See Ctapp WL et a! 627

Braam B See Rabelink TJ et at 376Brandt RR See Mattingly MT et at 744Branger B See Gris J-C et at 807Brasier AR, Li J, Coptand A: Transcription factors

modulating angiotensinogen gene expression inhepatocytes 1564

Bravo J (abst) 583Brendolan A See Ronco C et al 47:S-18Brenner BM See Simons JL et a! 396Brenner BM See Zhang PL et at 414Breyer JA See Ikizler TA et at 1178Bricio T (abst) 559Brimer CM (abst) 939Briso-Montiano JM (abst) 570Broe MED See Fels LM et at 46:S-81Brouwer E (abst) 1459Brouwer E See Kattenberg CGM et at 1Brown S See Gaber L et a! 161Bruggeman LA See Ray PE et at 759Bruguera M (abst) 573Bruijn JA (abst) 1460, 1461, 1462, 1464, 1469, 1471Bruijn JA See Bergijk EC et a! 1663Brunaccini A See Gesualdo L et at 1002Bruneet M-F (abst) 1244Brunet-Lecompte P (abst) 1247Bruneval P See Véniant M et at 421Brunkhorst R, Wrenger E, Krautzig S, Ehterding G,

Mahiout A, Koch K-M: Clinical experience with homeautomated peritoneat dialysis 47:S-25

Brunner H (abst) 1461Bryan CF See Pereira BJG et al 886Bryant JL See Ray PE et at 759Buades J (abst) 563, 582Bucciante G See Piccoli A et at 534BUch M See Rettig R et al 1536Buchanan R (abst) 938Bueno V (abst) 1750Buis B (abst) 1467Bundschuh I See Fels LM et al 46:S-81Buño A (abst) 566Buoncristiani U See Giovenati P et a! 1616Burke TJ (abst) 1747Burnett JC Jr See Mattingly MT et a! 744Burns KD See Cheng H-F et at 1603Burns NJT See Whitworth CE et a! 1528Bushinsky DA See Sprague SM et at 1199Busson M (abst) 1242Bustamante J (abst) 570, 570, 570Bustamante R (abst) 570, 570, 570Bustos de Abajo M (abst) 583Butkowski Ri See Carone FA et at 1368Butter J (abst) 923Buttyan R (abst) 926

Buysmann S (abst) 1465, 1468Buysmann S See Bemetman FJ et at 1674

CCaballero Morales T (abst) 584Cabelto V (abst) 561Cabrejas C (abst) 568Cachero M (abst) 582Calvar C (abst) 572Calvo C (abst) 565, 565Cam G See Simon P et a! 1192Camargo E (abst) 1752

1768 Author Index: Vol. 46

Cambar J See Zhao J et al 717Cameron JS See Hernando L et al 1594Cameron JS See Suassuna JHR et a! 443Campbell S (abst) 923

Campbell SB (abst) 941

Campestre W (abst) 1739Campistol JM (abst) 577Campos SB (abst) 1747, 1747Camps J (abst) 563, 564, 564, 565, 568, 579, 579Cancellotti C See Giovenali P et a! 1616Canessa M See Pontremoli R et a! 365

Cangussu L (abst) 1745Cannata AndIa JB (abst) 587Cannata JB (abst) 587, 587, 587, 587Cannella G, Bonucci E, Rolla D, Ballanti P, Moriero E,

De Grandi R, Augeri C, Claudiani F, Di Maio G:Evidence of healing of secondary hyperparathyroidismin chronically hemodialyzed uremic patients treatedwith long-term intravenous calcitriol 1124

Canziani ME (abst) 1753Canziani MEF (abst) 1747Capasso G See Unwin R et al 1092Cape! P See Abramowicz D et al 1596Caracuel Ruiz MD (abst) 583Caraips A (abst) 558, 559, 571, 581, 582Caramori JST (abst) 1746Carbonell JM (abst) 560Carceller F (abst) 555Caridad A (abst) 576, 576Carlomagno A See Fern C et al 780Carney SL (abst) 931Carone FA, Butkowski Ri, Nakamura 5, Polenakoviè M,

Kanwar YS: Tubular basement membrane changesduring induction and regression of drug-inducedpolycystic kidney disease 1368

Carrera M (abst) 555Carreras L (abst) 555Carrière S See Wang T-T et a! 703Carrió J (abst) 554, 554, 557, 565, 573Carta S See Cianciulli P et a! 467Carvaiho AB (abst) 1751, 1751Carvaiho AF (abst) 1751Carvalho PR (abst) 1739Casais LA (abst) 572Casals M (abst) 571Casanovas T (abst) 572Cases A (abst) 574, 574, 574Cassiolato JL (abst) 1753Cassola AC (abst) 1752Cassuto-Viguier E (abst) 1245Casteifleiras MJ (abst) 584Castelao AM (abst) 557, 558, 572, 573, 584Castell J (abst) 556Castellote E (abst) 559, 571, 581, 582Castillo D (abst) 575, 581Castro I (abst) 1742Castro MCM (abst) 1738, 1746Catanzaro DF, Sun J, Gilbert MT, Yan Y, Black T,

Sigmund C, Gross KW: A Pit-i binding site in thehuman renin gene promoter stimulates activity inpituitary, placental and juxtaglomerular cells 1513

Caterson Ri (abst) 921, 923, 924, 929, 933, 940, 940Catt KJ See Hunyady L et al 1496Cattran D See Hebert LA et a! 1688Cavalcanti FCB (abst) 1745

Celis R (abst) 573Cembrano J (abst) 557Cendoroglo M (abst) 1738, 1753Cendoroglo MN (abst) 1747Cendoroglo Neto M (abst) 1753Cerezo S (abst) 556, 556, 561, 569, 569, 569, 569, 574Cesar KR (abst) 1742Cezaretti ML (abst) 1739Chacon JC (abst) 574Chada K See Duncan MK et a! 324Chahin Haddad J (abst) 559Chaimovitz C See Douvdevani A et a! 993Chaki S, Guo D-F, Yamano Y, Ohyama K, Tani M,

Mizukoshi M, Shirai H, Inagami T: Role of carboxyltail of the rat angiotensin II type iA receptor inagonist-induced internalization of the receptor 1492

Chan JCM See Pandak WM et al 358Chan JSD See Wang T-T et a! 703Chang L (abst) 938, 939Chang M See Johnson RJ et a! 1700Chang PC See Florijn KW et a! 252Chang-Zheng T (abst) 923Charasse C See Simon P et a! 1192Charlesworth JA (abst) 933, 934Chatani F See Kim S et a! 1346Chatterjee P See McLay iS et a! 1043Chatziantoniou C, Dussaule J-C, Arendshorst WJ,

Ardaillou R: Angiotensin II receptors and reninrelease in rat glomerular afferent arterioles 1570

Chatzilias A See Daneman D et a! 1154Chauveau D (abst) 1246Chen H-C See Tan M-S et a! 690Chen J (abst) 932, 937Chen L (abst) 932Chen M See Wang T-T et a! 703Cheng H-F, Burns KD, Harris RC: Reduced proximal

tubule angiotensin II receptor expression instreptozotocin-induced diabetes mellitus 1603

Cheung AK, Parker CJ, Hohnholt M: Solublecomplement receptor-Type 1 inhibits complementactivation induced by hemodialysis membranes in vitro... 1680

Cheung PK (abst) 1462Cheung RC See Pereira BJG et a! 886Chevet D (abst) 1247Chiaramonte S See Ronco C et a! 47:S-18Chine M (abst) 575, 575, 575Chinelato MMR (abst) 1745Chini CCS, Chini EN, Williams JM, Matouovic K,

Dousa TP: Formation of reactive oxygen metabolitesin glomeruli is suppressed by inhibition of cAMPphosphodiesterase isozyme type IV 28

Chini EN See Chini CCS et a! 28Chiu L See Reudelhuber TL et a! 1522Chon Y See Goodman WG et a! 1160Chou ST (abst) 937Choudhury GG, Biswas P, Grandaliano G, Fouqueray B,

Harvey SA, Abboud HE: PDGF-mediated activationof phosphatidylinositol 3 kinase in human mesangialcells 37

Chow M-P (abst) 924Christophe JL (abst) 1246Churchill DN: Adequacy of peritoneal dialysis: How

much dialysis do we need9 47:S-2


Cianciulli P, Sollecito D, Sorrentino F, Forte L, GilardiE, Massa A, Papa G, Carta 5: Early detection ofnephrotoxic effects in thalassemic patients receivingdesferrioxamine therapy 467

Cinotti GA See Menè P et al 122Cirillo M, Laurenzi M, Panarelli W, Stamler J: Urinary

sodium to potassium ratio and urinary stone disease... 1133Ciudad J (abst) 578, 586Clapp WL, Bowman P, Shaw GS, Patel P, Kone BC:

Segmental localization of mRNAs encoding Na-K-ATPase a- and a-subunit isoforms in rat kidney usingRT-PCR 627

Clapp WL See Mohaupt MG et al 653Clark RG See Hazel SJ et al 58Clark WR, Macias WL, Molitoris BA, Wang N-HL:

Membrane adsorption of 32-microg1obulin:Equilibrium and kinetic characterization 1140

Clarke P (abst) 923Clarkson AR (abst) 940Claudiani F See Cannella G et al 1124Clement J (abst) 1468Clozel i-P See Véniant M et al 421Coates RJ See Soucie JM et al 893Cockayne D (abst) 936

CofànF(abst) 581Coghian JP, Corvol P: Introduction 1477Coghlan JP See Darby IA et al 1557Coghlan JP See McKinley Mi et al 1479Coghlan JP See Roche PJ et al 1580Cogné M See Preud'homme J-L et al 965

Cogny van Weydevelt F (abst) 1242Cohen AF (abst) 1468Cohen AS (abst) 577Cohen MAH, Kumpe DA, Durham JD, Zerdlinger SC:

Improved treatment of thrombosed hemodialysisaccess sites with thrombolysis and angioplasty 1375

Cohen Tervaert JW (abst) 1463Coles GA, Williams iD: The management of

ultrafiltration failure in peritoneal dialysis 47:S-14Coles GA See Donovan KL et al 1431Coles GA See Gahl GM et a! 47:S-1Coles GA See Topley N et al 900Coles GA See Yung S et al 527Colomé-Serra FM See Moreso F et al 1721Combe C (abst) 1243, 1243, 1243Combe C, Aparicio M: Phosphorus and protein

restriction and parathyroid function in chronic renalfailure 1381

Concepción M (abst) 563Conger JD, Schultz MF, Miller F, Robinette JB:

Responses to hemorrhagic arterial pressure reductionin different ischemic renal failure models 318

Congiu M See Darby IA et al 1557Conners MS See Macica CM et a! 113

Connolly J (abst) 941Conthe P (abst) 561Contreras i (abst) 580, 580, 581Conz P See Ronco C et al 47:S-18Cooper ES See Pereira BJG et al 886Cooperative Group of Nephrologic Centers (abst) 1741Cope GH See Shehata M et al 726Copland A See Brasier AR et a! 1564Corboy i (abst) 929

Corboy i, Sutherland WH, Walker Ri, Robertson MC,Cox CM: Cholesteryl ester transfer in patients withrenal failure or renal transplants 1147

Corboy JM (abst) 936Córdoba i (abst) 585Coronel F See Herrero JA et al 1167Corradini AM (abst) 923Corvol P See Coghian JP et al 1477Cosio FG, Falkenhain ME, Sedmak DD: Association of

thin glomerular basement membrane with otherglomerulopathies 471

Cosio FG, Shibata T, Rovin BH, Birmingham Di:Effects of complement activation products on thesynthesis of decay accelerating factor and membranecofactor protein by human mesangial cells 986

Cossart Y (abst) 923Costa CA (abst) 1747Costa Silva VL (abst) 1744Cotter BR See Daneman D et al 1154Couroucé A-M See Simon N et al 504Couser W See Johnson Ri et al 1255Couser WG (abst) 1461Couser WG See Johnson Ri et al 1700Couser WG See Savin Vi et al 382Couttenye MM (abst) 1461Covarsi A (abst) 559, 572Cox CM (abst) 929Cox CM See Corboy i et al 1147Crabbé i (abst) 1246

Craig B (abst) 928Craig JC (abst) 935Craik Di (abst) 931Craven PA See Studer RK et a! 1074

Crespo J (abst) 585, 585Crompton CH See Daneman D et al 1154Cross M (abst) 936Cruceyra A See Herrero JA et al 1167Cruciatti A See Messa P et al 1713Crutcher E See Price RG et al 46:S-25Cruz iM (abst) 585Cruzado iM (abst) 555, 557, 558Cuevas B (abst) 555Cuevas P (abst) 555Cuevas X (abst) 575, 575, 575Cui X See Trifillis AL et al 1083Cumming AD See Whitworth CE et al 1528Cunningham J See Armstrong A et al 47:S-51

Cuppari L (abst) 1741Curtis ii See iulian BA et al 1397

Cybulsky MI (abst) 1463

DD'Agati V: The many masks of focal segmental

glomeruloscierosis (Nephrology Forum) 1223Daha M (abst) 1470Daha MR (abst) 1460, 1461, 1462, 1468, 1471Daha MR See van den Dobbelsteen MEA et al 512Daher EF (abst) 1745Dalboni MA (abst) 1747Dale i (abst) 923D'Aloia M-AE See Noble AR et al 1588Daneels RF (abst) 1470Daneman D, Crompton CH, Balfe iW, Sochett EB,

Chatzilias A, Cotter BR, Osmond DH: Plasmaprorenin as an early marker of nephropathy in diabetic(IDDM) adolescents 1154


Danser AFIJ (abst) 1460Dantas RC (abst) 1747

d'Apice AJF (abst) 932

Darby IA (abst) 943

Darby IA, Congiu M, Fernley RT, Sernia C, Coghian JP:Cellular and ultrastructural location ofangiotensinogen in rat and sheep kidney 1557

Das Neves FC See Suassuna JHR et al 443Dasgupta MK, Larabie M, Hailoran PF: Interferon-

gamma levels in peritoneal dialysis effluents: Relationto peritonitis 475

David-Neto E (abst) 1743Davies D (abst) 938Davies M See Martin J et al 877Davies M See Topley N et al 900Davies M See Yung S et al 527Davis C See Johnson RJ et a! 1255Davis P (abst) 926Dawborn J (abst) 940de Bonis E (abst) 560De Broe ME (abst) 1461, 1462, 1470de Broe ME See Nouwen EJ et al 46:S-43de Freitas CC (abst) 1750De Grandi R See Cannella G et al 1124De Heer E (abst) 1461, 1462, 1469de Heer E See Bergijk EC et al 1663

de Jong P (abst) 1467de Jong PE (abst) 1463, 1463, 1465, 1472de la Higuera MC (abst) 570De Leon B (abst) 577, 578de Melker HE (abst) 1470

de Miguel MA (abst) 575de Oña M (abst) 582De Paepe ME, Trudel M: The transgenic SAD mouse: A

model of human sickle cell glomerulopathy 1337de Paula A (abst) 567, 567De Pauw L See Abramowicz D et a! 1596de Précigout V (abst) 1243de Souza RR (abst) 1739de Waart DR See Zemel D et al 1422de Wardener HE See Woolfson RG et al 297de Zeeuw D (abst) 1463, 1463, 1465, 1467, 1472Dechaux M See Maniar S et al 1705Deckert M (abst) 1245Deen PMT (abst) 1467

Degeilh F (abst) 1245Deira J (abst) 577, 578Deira JL (abst) 578del Peso G (abst) 558del Villar V (abst) 570Delalandre A See Wang T-T et al 703DeLco M (abst) 938Deihanty PJD See Matsell DG et al 1030Delling G See Amling M et al 733DeLuca DJ See Schelling JR et al 675Deng X, Welch WJ, Wilcox CS: Renal vasoconstriction

during inhibition of NO synthase: Effects of dietarysalt 639

Denis F (abst) 1246Denoroy L See Preud'homme J-L et al 965Derkx F (abst) 1470Derkx FH (abst) 1460Derkx FHM (abst) 1460, 1469DeRubertis FR See Studer RK et al 1074

Deschepper CF: Angiotensinogen: Hormonal regulationand relative importance in the generation ofangiotensin II 1561

Descombes E See Gabriel J-P et al 789Devuyst 0 (abst) 1246Dewan PA (abst) 922DeWolf R See Gellai M et al 1287D'Haese PC (abst) 1461, 1470Di Maio G See Cannella G et al 1124Di Paoio S See Gesualdo L et al 1002Diamandis EP See Papanastasiou P et al 216Dias EPO (abst) 1748Dias GM (abst) 1740Dichtchekenian V (abst) 1739D'Iddio S See Giovenali P et al 1616Diethelm AG See Julian BA et al 1397Diez A (abst) 561DIez JJ, Iglesias PL, Sastre J, GOmez-Pan A, Selgas R,

MartInez-Ara J, Miguel JL, Méndez J: Influence oferythropoietin on paradoxical responses of growthhormone to thyrotropin-releasing hormone in uremicpatients 1387

DIez-Marqués ML See Garcia-Escribano C et al 1611

Digenis P (abst) 1461

Dijkman HBPM (abst) 1467Dileepan KN See Li JZ et a! 1025Dinkla C See Zemel D et al 1422Distler A See Hailer H et al 1653Divakar D (abst) 925Dixit MP (abst) 928Do YS See Morris BJ et al 1516Doddrell D (abst) 936Doerschuk CM See Andreoli SP et al 1100Donald RA (abst) 930Donate T (abst) 582Donckerwolcke RAMG (abst) 1470Donker AJM (abst) 1471Donnenberg MS See Trifillis AL et al 1083Donovan KL, Coles GA, Williams JD: An ELISA for

the detection of type IV collagen in human urine—Application to patients with glomerulonephritis(Technical Note) 1431

Dousa TP See Chini CCS et al 28Douthat W (abst) 587, 587Doutrelepont J-M See Abramowicz D et al 1596Douvdevani A, Rapoport J, Konforty A, Argov S, Ovnat

A, Chaimovitz C: Human peritoneal mesothelial cellssynthesize IL-la and J3 993

Dowling JP (abst) 937Drab M See Wagner J et al 1542Draibe S (abst) 1738, 1753Draibe SA (abst) 1747, 1749, 1751, 1751, 1752, 1753Drummond MAM (abst) 1740Duarte AJS (abst) 1744, 1751Dubot P (abst) 1247Dubyak GR See Schelling JR et a! 675Ducamp S See Simon N et al 504Dufloth D (abst) 1740

Duggan KA (abst) 934Dunbar R (abst) 937, 942Duncan MK, Shimamura T, Chada K: Expression of the

helix-loop-helix protein, ID, during branchingmorphogenesis in the kidney 324

Dunlop M (abst) 930Dunn MJ See Kester M et al 1404


Dunn MJ See Schramek H et a! 1644Dupré-Goudable C (abst) 1242Duran JC (abst) 579Durand D (abst) 1242, 1242Durão M (abst) 1753Durham 3D See Cohen MAR et al 1375Dussaule J-C See Chatziantoniou C et al 1570Dyne M (abst) 936Dzau VJ See Sasamura H et a! 1499

EEchevarrIa 3 (abst) 568Ecija JL (abst) 560Eckardt K-U See Schafer K et al 134Eddie LW See Roche PJ et al 1580Edel H See Hofmann W et al 46:S-111Edwards RG See Newman DJ et a! 46:S-20Ehierding G See Brunkhorst R et a! 47:S-25Ehiers JA (abst) 1747Ellis CN See Young EW et al 1216Ellwanger S See Morcos M et a! 1627Elorriaga R (abst) 587, 587ELzie JL See Mohaupt MG et al 653Endege W See Tan M-S et al 690Endo F See Nakazato H et a! 1307Endre ZH (abst) 936, 936Epstein M (abst) 1460Ercilla MG (abst) 573Erlich JH (abst) 927, 934, 942Errasti P (abst) 563, 582Escalada P (abst) 554, 554, 555Escalante BA See Macica CM et al 113Esforzado N (abst) 574, 574Esnault VLM, Short AK, Audrain MAP, Jones SJ,

Martin SJ, Skehel 3M, Lockwood CM: Autoantibodiesto lactoferrin and histone in systemic vasculitisidentified by anti-myeloperoxidase solid phase assays . . . 153

Español MT (abst) 579Espiner EA (abst) 936Espinosa M (abst) 575, 576Esteban 3 (abst) 566Esteban Morcillo 3 (abst) 566Estevan 3M (abst) 554Etheridge MR (abst) 926Evans MJ (abst) 930Evered M See McKinley MJ et al 1479

FFaas MM (abst) 1469, 1471Fadda GZ See Sahai A et a! 1069Fagalde A (abst) 1461Falk MC (abst) 940Falkenberg FW See Bomhard EM et a! 46:S-60Falkenberg FW See Limberg R et a! 46:S-97Falkenhain ME See Cosio FG et a! 471Fanning GC (abst) 940Faoagali 3 (abst) 923Farias MG, Soucie JM, McClellan W, Mitch WE: Race

and the risk of peritonitis: An analysis of factorsassociated with the initial episode 1392

Fault RJ (abst) 927Fawcett JP (abst) 927Feith GW (abst) 1462Felip A (abst) 558Felippe MJDB (abst) 1746

Felippe, Jr 3 (abst) 1745Fellay G See Gabriel i-P et a! 789Fels LM, Bundschuh I, Gwinner W, Jung K, Pergande

M, Graubaum H-J, Price RG, Taylor SA, Broe MED,Nuyts GD, Mutti A, Franchini I, Lauwerys R, RoelsH, Bernard A, GelpI E, Rose!ló 3, Hotter G, Stolte H:Early urinary markers of target nephron segments asstudied in cadmium toxicity 46:S-81

Felsenfeld AJ See Bover 3 et al 310Fenocchio D See Giovenali P et a! 1616Feriani M See Ronco C et at 47:S-18Fernánadez G (abst) 565Fernández A (abst) 582Fernandez F (abst) 582Fernandez Fernandez 3 (abst) 567Fernández 0 (abst) 565Fernández Martin JL (abst) 587, 587, 587Fernández MJ (abst) 566Fernandez R (abst) 1742Fernández Ruiz E (abst) 561

Fernandez-Gal!ego J (abst) 572Fernandez-Lucas M (abst) 575Fernández-Urdanibia 3 (abst) 559

Fernández-Vega F (abst) 554, 554, 555Fernley RT See Darby IA et a! 1557Ferraz MLG (abst) 1748Ferreira Fi!ho SR (abst) 1749Ferreri NR See Macica CM et al 113Fern C, Bellini C, Carlomagno A, Perrone A, Santucci

A: Urinary kallikrein and salt sensitivity in essentialhypertensive males 780

Feuillan P See Aguilera G et a! 973Fick GM, Gabow PA: Hereditary and acquired cystic

disease of the kidney 951

Fidalgo A (abst) 574Field MJ (abst) 931, 935, 936, 937Figueiredo iF (abst) 1748Fillola G (abst) 1242Findon G (abst) 942Fiol C (abst) 584Fireman FAT (abst) 1750Flakoll P3 See Ikizier TA et a! 830Fleming S See Whitworth CE et al 1528Fleming SJ (abst) 923, 941Fliser D, Schröter M, Neubeck M, Ritz E:

Coadministration of thiazides increases the efficacy ofloop diuretics even in patients with advanced renalfailure 482

Fliser D See Ritz E et a! 46:S-76Flonijn KW (abst) 1472Florijn KW, Barendregt JNM, Lentjes EGWM, van Dam

W, Prodjosudjadi W, van Saase JLCM, van Es LA,Chang PC: Glomerular filtration rate measurement by"single-shot" injection of inulin (Technical Note) 252

Foley R See Barrett BJ et a! 1118Fonollosa V (abst) 563Fonseca MA (abst) 1740Forbes 1K (abst) 937Ford-Hutchinson AW See Petric R et a! 1322Forster H (abst) 1460Forsyth K (abst) 940Fort 3 (abst) 563, 564, 564, 565, 568, 579, 579Forte L See Cianciulli P et a! 467Fouqueray B See Boutard V et at 1280Fouqueray B See Choudhury GG et at 37


Fourcade J See Gris J-C et a! 807Fournier AM (abst) 932Fradin MS See Young EW et al 1216Fraenkel M (abst) 943Fraenkel MB (abst) 934Fraile M (abst) 556, 568Franchini I See Fels LM et a! 46:S-81Franco M See Bobadilla NA et a! 773Franco RJS (abst) 1738Fransen R (abst) 1459Frei U See JOrres A et al 47:S-79Freitas, Jr IF (abst) 1738Fries W See Gambaro G et a! 797Fritz 0 (abst) 1242Frutos MA (abst) 572Fuchs D, Stahi-Hennig C, Gruber A, Murr C, Hunsmann

G, Wachter H: Neopterin—Its clinical use in urinalysis . 46:S-8

Fujimura MD (abst) 1746Fujisawa G See Tsuboi Y et al 237Fujishima M See Okuda S et al 1635Fukagawa M See Kitaoka M et al 1110Fukamizu A, Watanabe M, Inoue Y, Kon Y, Shimada S,

Shiota N, Sugiyama F, Murakami K: Corticalexpression of the human angiotensinogen gene in thekidney of transgenic mice 1533

Fukuda K See Okuda S et al 1635Fukui K See Takahashi S et a! 1525Fukunaga Y See lenaga K Ct al 46:S-22Fuller PJ (abst) 933Fuller PJ See Stein-Oakley AN et al 1204Fulquet M (abst) 575, 575, 575Fung LH (abst) 940

GGaber L, Walton C, Brown S, Bakris G: Effects of

different antihypertensive treatments on morphologicprogression of diabetic nephropathy inuninephrectomized dogs 161

Gabow PA See Fick GM et al 951Gabriel J-P, Fellay G, Descombes E: Urea kinetic

modeling: An in vitro and in vivo comparative study. . . . 789Gahl GM, Jörres A, Topley N, Coles GA, Williams JD:

Introduction 47:S-1Gahi GM See Jorres A et al 47:S-79Gailit J See Noiri E et al 1050Gainza J (abst) 583Galan A (abst) 558, 570Gales B See Goodman WG et al 1160Gallego JL (abst) 569Gambaro G, Venturini AP, Noonan DM, Fries W, Re

0, Garbisa 5, Milanesi C, Pesarini A, Borsatti A,Marchi E, Baggio B: Treatment with aglycosaminoglycan formulation amelioratesexperimental diabetic nephropathy 797

Gámez C (abst) 567Gándara A (abst) 581Gandoipho L (abst) 1741Gans ROB (abst) 1471Gansevoort RT (abst) 1465Ganten D See Wagner J et a! 1542Garbisa S See Gambaro G et al 797Garc R (abst) 584Garcia Chicano MJ (abst) 584Garcia de Vinuesa MS (abst) 579, 579GarcIa del Moral R (abst) 560, 584

Garcia F (abst) 569, 569, 569Garcia H (abst) 565, 565Garcia J (abst) 561, 585Garcia Nieto V (abst) 559Garcia R (abst) 558, 580, 580, 580, 580, 580, 581, 584Garcia Ramon R (abst) 579Garcia Vinuesa MS (abst) 579Garcia WE (abst) 1748Garcia-Escribano C, Diez-Marqués ML, Medina-Alonso

J, Rodriguez-Puyol M, RodrIguez-Puyol D:Somatostatin activates particulate guanylate cyclase incultured rat mesangia! cells 1611

Garcia-Osuna R (abst) 555Garcia-Sierra F (abst) 561GarcIa-Torres R See Bobadilla NA et al 773Garcia-Valdecasas J (abst) .. 556, 556, 561, 569, 569, 569, 569,

574Gargalidis-Moudanos C (abst) 1243Garoni JA See Kreisberg JI et al 105Garoni JA See Kreisberg JI et a! 1019Garrancho JM (abst) 569Garrido Torres-Puchol A (abst) 584Garrigos E (abst) 580, 580, 580Gasalla-Herraiz J See Rodriguez-Commes J et al 666Gascón A (abst) ... 577, 577, 578, 578, 578, 586, 586, 586, 587Gaskin KJ (abst) 927Gasparo M, Levens NR: Pharmacology of angiotensin II

receptors in the kidney 1486Gaston RS See Julian BA et al 1397G Ramos JL (abst) 573Gavras H (abst) 1739Gavras I (abst) 1739Gawaz MP, Mujais SK, Schmidt B, Gurland HJ: Platelet-

leukocyte aggregation during hemodialysis 489Gaya J (abst) 574Gayoso P (abst) 566Gazo A See Maggi E et a! 869Geatti 0 See Messa P et a! 1713Geelen MJH (abst) 1463Geffriaud C See Kokolina E et al 177Gehlen F See Wagner J et al 1542Gellai M, DeWolf R, Pullen M, Nambi P: Distribution

and functional role of renal ET receptor subtypes innormotensive and hypertensive rats 1287

GelpI E See Fels LM et al 46:S-81Gengaro P (abst) 1747George N (abst) 923Gerstberger R See Rettig R et a! 1536Gesualdo L, Di Paolo S, Ranieri E, Schena FP,

Brunaccini A: Trapidi! inhibits human mesangial cellproliferation: Effect on PDGF f3-receptor binding andexpression 1002

Giampietro 0 See Matteucci E et a! 46:S-58Giebisch G See Unwin R et al 1092Gil FZ (abst) 1744Gilardi E See Cianciulli P et a! 467Gilbert MT See Catanzaro DF et a! 1513Gilge U See Schaefer L et a! 46:S-64Gillespie CM See Hazel SJ et al 58Gillies AHB (abst) 931Gillin AG (abst) 938Gil-Vernet S (abst) 572, 584Gimbrone, Jr MA (abst) 1463Gimenez-Gal!ego G (abst) 555


Ginosa M (abst) 1740Ginoza M (abst) 1739, 1740Ginsberg MH (abst) 927Giovenali P, Fenocchio D, Montanan G, Cancellotti C,

D'Iddio 5, Buoncristiani U, Pelagaggia M, Ribacchi R:Selective trophic effect of L-carnitine in type I and haskeletal muscle fibers 1616

Girolami JP (abst) 1245Glez Hernando C (abst) 569Go I (abst) 1470Gobé GC (abst) 926Goh DW (abst) 922Goicoechea M (abst) 563, 579Gokal R See Mistry CD et al 496Goldman M See Abramowicz D et al 1596Goidraich NP (abst) 1746Goligorsky MS See Noiri E et al 1050Gomez A See Pankewycz OG et al 748Gómez Alonso C (abst) 587Gómez D (abst) 585GOmez E (abst) 554, 555, 582Gómez I (abst) 586Gómez Morales M (abst) 560, 584Gómez T (abst) 576Gomez-Martino JR (abst) 559, 572Gómez-Pan A See DIez JJ et al 1387Gómez-Ullate P (abst) 583Gonçalves LF (abst) 1743Goñi M (abst) 570Gonzalez CM (abst) 577Gonzalez DIaz I (abst) 581Gonzalez E (abst) 554, 582Gonzalez JM (abst) 568Gonzalez L (abst) 581Gonzalez MT (abst) 557, 558, 572, 573Gonzalez Parra E (abst) 567, 568Gonzalez R (abst) 576, 579González-Posada JM (abst) 560Gonzalo A (abst) 559Goodman WG (abst) 1461Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales

B, Segre GV, Salusky IB: Development of adynamicbone in patients with secondary hyperparathyroidismafter intermittent calcitriol therapy 1160

Goodship THJ See Graham KA et al 47:S-47Goodyer C See Matsell DG et al 1030Gordon RD See Klemm SA et al 1591Górriz JL (abst) 573, 585, 585Grabowski P See McLay JS et al 1043Graham KA, Reaich D, Goodship THJ: Acid-base

regulation in peritoneal dialysis 47:S-47Granada M (abst) 558Grandaliano G See Choudhury GG et al 37Grass L See Papanastasiou P et al 216Graubaum H-J See Fels LM et al 46:S-81Greenhill N (abst) 937Gretch DR See Johnson RJ et al 1255Gretch DR See Johnson RJ et al 1700Gretz N See Schafer K et al 134Griffin KA, Picken M, Bidani AK: Radiotelemetric BP

monitoring, antihypertensives and glomeruloprotectionin remnant kidney model 1010

Grigg LE (abst) 921Grifló JM (abst) 572, 573, 584Grinyó JM See Moreso F et al 1721

Gris J-C, Branger B, Vécina F, Al Sabadani B, FourcadeJ, Schved J-F: Increased cardiovascular risk factorsand features of endothelial activation and dysfunctionin dialyzed uremic patients 807

Groisser DS See Young EW et al 1216Gross KW See Catanzaro DF et al 1513Grote HJ See Amling M et al 733Grubb A See Nilsson-Ehle P et al 46:S-17Grubb AO See Newman DJ et al 46:S-20Gruber A See Fuchs D et al 46:S-8GrUnfeld JP (abst) 1246GrUnfeld J-P See Kokolina E et al 177Gruss E (abst) 561, 562, 565Gualde N (abst) 1243Guan J-X See Pankewycz OG et al 748Guder WG, Baines AD, Itoh Y, Nilsson-Ehle P: New

Markers of Renal Diseases—Introduction 46:S-1Guder WG See Hofmann W et al 46:S-111Gudivaka R See Ho LT et al 1438Guerra PCG (abst) 1740Guerrero A (abst) 561Guijarro C (abst) 562Guillaumie J (abst) 1247Guo D-F See Chaki S et al 1492Gurland HJ See Gawaz MP et al 489Gurrath M See Noiri E et al 1050Gutierrez A, Bergstrom J, Alvestrand A: Hemodialysis-

associated protein catabolism with and without glucosein the dialysis fluid 814

Gwinner W See Fels LM et al 46:S-81Gyory AZ (abst) 922, 935, 936Gyurko R See Phillips MI et al 1554

HHa H, Yoon SJ, Kim KH: High glucose can induce lipid

peroxidation in the isolated rat glomeruli 1620Hadad SJ (abst) 1752, 1752Hagège J See Nguyen G et al 208Hagen EC (abst) 1462Hahn M See Amling M et al 733Haites NE See McLay JS et al 1043Hakim RM See Ikizier TA et a! 830Hakim RM See Ikizier TA et al 1178Halbwachs-Mecarelli L See Kokolina E et a! 177Hall Eliza (abst) 939Haller H, Lindschau C, Quass P, Distler A, Luft FC:

Nuclear calcium signaling is initiated by cytosoliccalcium surges in vascular smooth muscle cells 1653

Halloran PF See Dasgupta MK et al 475Hamaguchi A See Kim S et a! 1346Hamann M See Schricker K et al 1330Hamilton TA See Young EW et al 1216Hammerman MR See Miller SB et a! 201Han VKM See Matsell DG et al 1030Hanesworth JM See Harding JW et al 1510Hanna JD See Pandak WM et al 358Hänsch GM See Morcos M et al 1627Hanss BG, Lewy JE, Van RC: Alterations in glomerular

dynamics in congenital, unilateral hydronephrosis 48Harding JW, Wright JW, Swanson GN, Hanesworth JM,

Krebs LT: AT4 receptors: Specificity and distribution.. 1510Härle M See Morcos M et al 1627Harley N (abst) 930Harrap SB: Public health, cardiovascular disease and

molecular biology 1546


Harrer S (abst) 931, 932Harris B (abst) 928, 928Harris DCH (abst) 924, 925, 932, 937, 941Harris RC See Cheng H-F et a! 1603Harris SJ (abst) 928Hart DNJ (abst) 930Hart J See Johnson RJ et al 1700Hartley RB See Suassuna JHR et al 443Hartog A (abst) 1459Harvey SA See Choudhury GG et al 37Hasan 0 (abst) 937, 942Hattori M (abst) 927Hattori S See Nakazato H et a! 1307Hauet Th (abst) 1242Hawkins T (abst) 922Hawksworth GM See McLay JS et a! 1043

Hawley C (abst) 923Hay JB See Yuan Z-Y et a! 520Hay N (abst) 923

Hay NM (abst) 924Hayslett JP See Rodriguez-Commes J et al 666Hazel SJ, Gillespie CM, Moore RJ, Clark RG, Jureidini

KF, Martin AA: Enhanced body growth in uremic ratstreated with IFG-I and growth hormone incombination 58

Heaf JO See Joffe P et al 838Heale W (abst) 939, 940Hebert LA, Bain RP, Verme D, Cattran D, Whittier FC,

Toichin N, Rohde RD, Lewis EJ: Remission ofnephrotic range proteinuria in Type I diabetes 1688

Heckl-Ostreicher B See Morcos M et a! 1627Hefferton D See Barrett BJ et al 1118Heidenreich S See Tepel M et a! 696Heidland A See Schaefer L et al 46:S-64Heilberg IP (abst) 1741, 1741, 1741Heimann JC (abst) 1739, 1739HeimbUrger 0, Bergstrom J, Lindholm B: Maintenance

of optimal nutrition in CAPD 47:S-39Hell NS (abst) 1739Heilmark T, Johansson C, Wieslander J:

Characterization of anti-GBM antibodies involved inGoodpasture's syndrome 823

Heiwig J-J (abst) 1244Hemmingsen L See Holm J et al 46:S-105Hené RJ (abst) 1464Hené RJ, van der Grond J, Boer WH, Mali WPT,

Koomans HA: Pre-transpiantation assessment of renalviability with 31P magnetic resonance spectroscopy .... 1694

Heng P'F (abst) 935Hennequin C (abst) 1244, 1245Hennessy A (abst) 938Henning PH (abst) 928Henry I See Junien C et a! 1264Hepburn DJ (abst) 925Hermans J (abst) 1471Hermenegildo M (abst) 573Hernández D (abst) 560, 578Hernández E (abst) 562, 562, 570, 576, 576Hernandez J (abst) 569Hernandez Perez J (abst) 567Hernandez-Jaras J (abst) 570Hernando L, Cameron JS: Message from the President.. 1594Hernendez G (abst) 581Herrera J (abst) 556, 571, 571Herrera-Acosta J See Bobadilla NA et al 773

Herrero JA, Trobo JI, Torrente J, Torralbo A, TorneroF, Cruceyra A, Coronel F, Barrientos A: Hemodialysiswith acetate, DL-lactate and bicarbonate: Ahemodynamic and gasometric study 1167

Herrero M (abst) 571, 572Hervas JO (abst) 556, 561, 569, 569Heublein DM See Mattingly MT et a! 744Heudes D See Véniant M et al 421Heuman DM See Pandak WM et al 358Hewitson T (abst) 943Hewitt 1K (abst) 940Heyn-Lamb R See Pereira BJG et al 886Hibberd AD (abst) 933Higashi H See Okuda S et al 1635Higashiyama S See Tan M-S et a! 690Hill PA (abst) 927Hindrichsen S (abst) 1468Hisada Y See Wada T et a! 455Ho LT, Kushner RF, Schoeller DA, Gudivaka R, Spiegel

DM: Bioimpedance analysis of total body water inhemodialysis patients (Technical Note) 1438

Ho RTH See Lai KN et a! 862Ho WKW (abst) 933Hobbs JB (abst) 925Hobisch A See Pfaller W et al 46:S-68Hoedemaeker PhJ (abst) 1461Hofmann W, Regenbogen C, Edel H, Guder WG:

Diagnostic strategies in urinalysis 46:S-111Hogg Ri (abst) 928Hohnholt M See Cheung AK et a! 1680Holdsworth SR (abst) 926, 927, 934, 942, 942Holdsworth SR See Huang XR et a! 69Holdsworth SR See Tipping PG et a! 79Hollander AAM (abst) 1464Hollander AAMJ (abst) 1465, 1468, 1472Holm J, Nielsen NV, Hemmingsen L: Retinopathy in

Type II diabetes mellitus associated with above-normalurinary excretion of RBP 46:S-105

Holmer S See Kramer BK et al 1577Holmer S See Schricker K et al 1539Holmes CJ: Peritoneal host defense mechanisms in

peritoneal dialysis 47:S-58HolthOfer H See Kester M et a! 1404Homma T See Yoshioka T et a! 405Homsi E (abst) 1739, 1748Hongwei W (abst) 933Hope RN (abst) 939HOmer D See Ritz E et al 46:S-76Hortal L (abst) 582Horvath JS (abst) 938Hostetter TH: Chronic transplant rejection (Nephro!ogy

Forum) 266Hotta 0, Taguma Y, Yusa N, Ooyama M: Analysis of

mononuclear cells in urine using flow cytometry inglomerular diseases 46:S-117

Hotter G See Fels LM et al 46:S-81Hoy W (abst) 928, 930Hsu CH, Patel SR, Young EW, Vanholder R: The

biological action of calcitriol in renal failure (EditorialReview) 605

Hsu CH See Patel SR et al 129Hsu H See Pereira BJG et al 886Hsueh WA See Morris BJ et a! 1516Huang T-P (abst) 924Huang XR (abst) 926, 942


Huang XR, Holdsworth SR, Tipping PG: Evidence fordelayed-type hypersensitivity mechanisms inglomerular crescent formation 69

Huang XR See Tipping PG et a! 79Huisman RM (abst) 1472Huitema MG (abst) 1459Hunsmann G See Fuchs D et al 46:S-8Hunyady L, Tian Y, Sandberg K, Balla T, Catt KJ:

Divergent conformational requirements forangiotensin II receptor internalization and signaling... 1496

Hurault de Ligny B (abst) 1242Hurst P (abst) 941Hyldstrup L See Joffe P et a! 838

IIanhez LE (abst) 1743Ibels L (abst) 922Ibels LS (abst) 921, 923, 929, 933, 940, 940Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S:

Localization of the complement regulatory proteins inthe normal human kidney 89

Ichikawa I See Yoshida H et al 1505Ichikawa I See Yoshioka T et al 405lenaga K, Nakamura K, Fukunaga Y, Nakano K,

Kanatsuna T: Creatol and chronic renal failure 46:S-22Iglesias PL See DIez JJ et al 1387lijima K See Nakanishi K et al 1413Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino

acid and albumin losses during hemodialysis 830Ikizler TA, Wingard RL, Breyer JA, Schulman G, Parker

RA, Hakim RM: Short-term effects of recombinanthuman growth hormone in CAPD patients 1178

Imholz ALT (abst) 1460, 1467, 1471Imholz ALT, Koomen GCM, Struijk DG, Arisz L,

Krediet RT: Fluid and solute transport in CAPDpatients using ultralow sodium dialysate 333

Imholz ALT See Krediet RT et al 47:S-7Imholz ALT See Zemel D et al 1422Inada Y See Kim S et al 1346Inagami T See Chaki S et al 1492Inagami T See Kambayashi Y et al 1502Inagami T See Yoshida H et al 1505Incentre Dialysis Staff (abst) 941Inoue H See Takahashi S et al 1525Inoue Y See Fukamizu A et al 1533Ippolito E See Aterini S et al 461Isales C See Rodriguez-Commes J et al 666Ishikawa S-e See Tsuboi Y et a! 237Ishimura Y See Kim S et al 1346Island MD See Mobley HLT et al 46:S-129Ito H See Nakanishi K et al 1413Ito K (abst) 927Itoh Y, Numata Y, Morita A, Asano Y, Kawai T: Varied

value of urinary N-acetyl-j3-D-glucosaminidaseisoenzyme B in males of reproductive age 46:S-38

Itoh Y See Guder WG et al 46:S-1Iwao H See Kim Set al 1346

JJabary NS (abst) 570, 570, 570Jablonski P (abst) 932, 933Jablonski P See Stein-Oakley AN et a! 1204Jacobs F (abst) 1244, 1244Janin G (abst) 1247Jansen JWCM See Rose UM et a! 223

Janssens PMW: New markers for analyzing the cause ofhematuria 46:S-115

Jara A See Bover J et al 310Jardine AG See McLay JS et al 1043Jiang R (abst) 927Jimenez ML (abst) 565Jiménéz NV (abst) 573Joannidis M See Pfaller W et al 46:S-68Joffe P, Heal JG, Hyldstrup L: Osteocalcin: A non-

invasive index of metabolic bone disease in patientstreated by CAPD 838

Jofre R (abst) 563Johansson C See Helimark T et a! 823Johnson DW (abst) 923, 941Johnson KJ See Young EW et a! 1216Johnson RJ, Gretch DR, Couser WG, Alpers CE,

Wilson i, Chang M, Hart J, Willson R: Hepatitis Cvirus-associated glomerulonephritis Effect of a-interferon therapy 1700

Johnson RJ, Willson R, Yamabe H, Couser W, AlpersCE, Wener MH, Davis C, Gretch DR: Renalmanifestations of hepatitis C virus infection 1255

Johnson Ri See Savin VJ et al 382Johnston MG See Yuan Z-Y et a! 520Johnstone LM (abst) 921Johston S (abst) 582Joles JA (abst) 1463Joles JA, Willekes-Koolschijn N, Scheek LM, Koomans

HA, Rabelink Ti, van Tol A: Lipoproteinphospholipid composition and LCAT activity innephrotic and analbuminemic rats 97

Jones C (abst) 943Jones CL (abst) 921Jones Si See Esnault VLM Ct a! 153Jordão-Bastos MG (abst) 1745

Jorgetti V (abst) 1744, 1744, 1744, 1751, 1752JOrres A, Gahl GM, Frei U: Peritoneal dialysis fluid

biocompatibility: Does it really matter7 47:S-79iörres A See Gahl GM et al 47:S-1JOrres A See Topley N et a! 900Jowett TP See Ong ACM et a! 1315Julian BA, Gaston RS, Barker CV, Krystal G, Diethelm

AG, Curtis JJ: Erythropoiesis after withdrawal ofenalapril in post-transplant erythrocytosis 1397

Junco E (abst) 561Jung K: Urinary enzymes and low molecular weight

proteins as markers of tubular dysfunction 46:S-29Jung K See Fels LM et a! 46:S-81Junien C, Henry I: Genetics of Wilms' tumor: A blend

of aberrant development and genomic imprinting(Editorial Review) 1264

Jureidini KF (abst) 928, 931, 932Jureidini KF See Hazel Si et a! 58

KKaasjager KAH See Rabelink Ti et al 376Kadkhodaee M (abst) 936Kaever V See Topley N et al 900Kagawa M See Nakanishi K et al 1413Kahalle S (abst) 1746Kaissling B See Schricker K et al 1330Kakuchi J See Yoshida H et al 1505Kaighati L See Rodriguez-Commes J et al 666Kallenberg CGM (abst) 1459


Kallenberg CGM, Brouwer E, Weening JJ, TervaertJWC: Anti-neutrophil cytoplasmic antibodies: Currentdiagnostic and pathophysiological potential 1

Kambayashi Y, Takahashi K, Bardhan S, Inagami T:Molecular structure and function of angiotensin type 2receptor 1502

Kan FSD (abst) 941Kanatsu K See Ono T et al 260Kanatsuna T See lenaga K et al 46:S-22Kanwar YS See Carone FA et al 1368Kapur S See Aguilera G et a! 973Karter J (abst) 1746Katoh T, Lakkis FG, Makita N, Badr KF: Co-regulated

expression of glomerular 12/15-lipoxygenase andinterleukin-4 mRNAs in rat nephrotoxic nephritis 341

Kawaguchi H (abst) 927Kawai T See Itoh Y et al 46:S-38Ke HQ See Patel SR et a! 129Keane WF: Lipids and the kidney (Nephrology Forum),.. 910Kelly CJ See Meyers CM et al 1295Kelly DJ See Rong P et al 1583Kemp G (abst) 921Kerjaschki D (abst) 926Kerlin P (abst) 923Kerr D See Sernia C et al 1574Kerr PG (abst) 922, 923, 929, 933Kessler H See Noiri E et al 1050Kester M, Nowinski RJ, Holthöfer H, Marsden PA,

Dunn MJ: Characterization of platelet-activating factorsynthesis in glomerular endothelial cell lines 1404

Khamlichi AA See Preud'homme J-L et a! 965Khan SR See Kok DJ et al 847Kievit P (abst) 1462Killen PD (abst) 1462Kim KH See Ha H et al 1620Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T,

Miura K, Inada Y, Wada T, Ishimura Y, Chatani F,Iwao H: Contribution of renal angiotensin II type Ireceptor to gene expressions in hypertension-inducedrenal injury 1346

Khn Y See Anderson SS et a! 1359Kincaid-Smith P (abst) 929King MJ (abst) 924Kinnaert P See Abramowicz D et a! 1596Kirkland GS (abst) 939Kirsztajn GM (abst) 1748, 1750Kirubakaran MG (abst) 922, 928Kirwin PJ (abst) 938Kitagawa K See Nakanishi K et al 1413Kitaoka M, Fukagawa M, Ogata E, Kurokawa K:

Reduction of functioning parathyroid cell mass byethanol injection in chronic dialysis patients 1110

Klahr S See Yanagisawa H et al 245Kleinknecht C See Maniar S et a! 1705Klemm SA, Ballantine DM, Gordon RD, Tunny TJ,

Stowasser M: The renin gene and aldosterone-producing adenomas 1591

Klimm H-P See Ritz E et a! 46:S-76Kiok PA (abst) 1459, 1469Kloppenburg WD (abst) 1463Klotman PE See Rappaport J et a! 16Klotman PE See Ray PE et al 759Kluijtmans L (abst) 1461Knight B (abst) 941Knight JF (abst) 927, 935, 940

Knoers NVAM (abst) 1467Knoers NVAM, van den Ouweland AMW, Verdijk MAJ,

Monnens LAH, van Oost BA: Inheritance ofmutations in the V2 receptor gene in thirteen familieswith nephrogenic diabetes insipidus 170

Knowiden J See Martin J et al 877Kobayashi K-i See Wada T et al 455Koch C See Limberg R et al 46:S-97Koch K-M See Brunkhorst R et al 47:S-25Koch V (abst) 1746Koene RAP (abst) 1461, 1462, 1465, 1467Kohlmann 0 (abst) 1739Kohlmann, Jr 0 (abst) 1740, 1740Koitabashi Y See Nakazato H et al 1307Kok DJ, Khan SR: Calcium oxalate nephrolithiasis, a

free or fixed particle disease 847Kokolina E, Noel L-H, Nusbaum P, Geffriaud C,

GrUnfe!d J-P, Halbwachs-Mecarelli L, Lesavre P:Isotype and affinity of anti-myeloperoxidaseautoantibodies in systemic vasculitis 177

Kokolo J (abst) 1247Kon V See Yoshioka T et al 405Kon Y See Fukamizu A et al 1533Kone BC See Clapp WL et al 627Kone BC See Mohaupt MG et al 653Konforty A See Douvdevani A et al 993Konieczkowski M See Schelling JR et al 675Konieczkowski M See Schramek H et a! 1644Kooijmans-Coutinho MF (abst) 1471Koomans HA (abst) 1459, 1463, 1464, 1469, 1470Koomans HA See Hené RJ et al 1694Koomans HA See Joles JA et al 97Koomans HA See Rabelink TJ et al 376Koonien GCM (abst) 1460, 1467, 1471Koomen GCM See Imholz ALT et al 333Koomen 0CM See Krediet RT et al 47:S-7Kootstra CJ (abst) 1469Kootte AMM (abst) 1465Kopp JB See Rappaport J et al 16Kopp JB See Ray PE et al 759Krall M See Pfaller W et al 46:S-68Kramer BK, Ritthaler T, Ackermann M, Holmer S,

Schricker K, Riegger GM, Kurtz A: Endothelium-mediated regulation of renin secretion 1577

Kramer BK See Schricker K et al 1539Krasilcic S (abst) 1748Krautzig S See Brunkhorst R et a! 47:S-25Krebs LT See Harding JW et al 1510Krediet RT (abst) 1460, 1467, 1471Krediet RT, Koomen GCM, Struijk DG, van Olden RW,

Imholz ALT, Boeschoten EW: Practical methods forassessing dialysis efficiency during peritoneal dialysis . 47:S-7

Krediet RT See Imholz ALT et a! 333Krediet RT See Zemel D et al 1422Kreis H (abst) 1244, 1245Kreisberg JI, Garoni JA, Radnik R, Ayo SH: High

glucose and TGFI31 stimulate flbronectin geneexpression through a cAMP response element 1019

Kreisberg JI, Radnik RA, Ayo SH, Garoni JA, SaikumarP: High glucose elevates c-fos and c-jun transcripts andproteins in mesangial cell cultures 105

Krieg RJ See Pandak WM et al 358Krieger NS See Sprague SM et a! 1199Kriz W See Schafer K et al 134Kruger K (abst) 1744, 1745


Krupa SM See Schmitz PG et a!Krystal G See Julian BA et alKumpe DA See Cohen MAH et alKurihara N See Yanagisawa H et a!Kurokawa K See Kitaoka M et a!Kurtz A See Kramer BK et alKurtz A See Schricker K et alKurtz A See Schricker K et a!Kurz P, Monier-Faugere M-C, Bognar B, Werner E,

Roth P, Viachojannis J, Malluche HH: Evidence forabnormal calcium homeostasis in patients withadynamic bone disease

Kushner RF See Ho LT et a!Kuwahara T See Ono T et alKyriazis AG (abst)

LLa Greca G See Ronco C et al 47:S-18Lachance S See Wang T-T et al 703Lafuente R (abst) 554, 565Lagarde C (abst) 1246Lago M (abst) 579, 579, 579Lai FM-m See Lai KN et a! 862Lai KN, Ho RTH, Leung JCK, Lai FM-rn, Li PKT:

Increased mRNA encoding for transforming factor-nin CD4+ cells from patients with IgA nephropathy . . . . 862

LaiKNSeeLiPKTeta! 185Lai Y-H See Tan M-S et al 690Lakkis FG See Katoh T et a! 341Lambert M-C See Larneire N et al 47:S-31Lamberts LV (abst) 1461, 1470Lameire N, Bernaert P, Lambert M-C, Vijt D:

Cardiovascular risk factors and their management inpatients on continuous ambulatoiy peritoneal dialysis.. 47:S-31

Lamers JMJ (abst) 1460Lamotte H (abst) 1245

Lampreabe I (abst) 583Lan HY (abst) 922, 926, 927Lane PH See Schmitz PG et a! 1184Langheinrich M See Wagner J et at 1542Lanuza M (abst) 580, 580, 581Laouari D See Maniar S et al 1705Laporta MP (abst) 580Lara Fortis L (abst) 584Larabie M See Dasgupta MK et al 475Laranja S (abst) 1741Larkins R (abst) 930Laruelle E See Simon P et al 1192Larumbe P (abst) 576Lau D (abst) 932Laurenzi M See Cirillo M et a! 1133Lauwerys R See Fels LM et al 46:S-81Lauwerys RR See Bernard AM et al 46:S-34Lavilla J (abst) 563, 582Law RE See Morris BJ et al 1516Lázaro JA (abst) 561Lea JP, Sands JM, McMahon SJ, Tumlin JA: Evidence

that the inhibition of Na7K-ATPase activity byFK506 involves calcineurin 647

Lebi A (abst) 1745Lebranchu Y (abst) 1242, 1242Lee M-E See Tan M-S et a! 690Lee Y-J See Tan M-S et al 690Legendre C (abst) 1244, 1244, 1245Leguen E (abst) 1243

Leichtman AB See Young EW et al 1216Lemarrec N See Simon N et al 504Lemmink H (abst) 1461Lemoniatou E (abst) 1461Lemos A (abst) 554Lcntjes EGWM See Florijn KW et al 252Leon B (abst) 587Leon C (abst) 559Leon M (abst) 562

Lepert JC (abst) 1245Lerma JL (abst) 577, 578, 578, 578, 587Leroux-Robert C (abst) 1246Lesavre P See Kokolina E et a! 177Leung JCK See Lai KN et a! 862Levens NR See Gasparo M et al 1486Levey AS See Pereira BJG et a! 886Lew SQ See Ronco C et al 47:S-18Lewis EJ See Hebert LA et al 1688Lewis LK (abst) 934Lewy JE See Hanss BG et al 48Li J See Brasier AR et al 1564Li JZ, Sharma R, Dileepan KN, Savin VJ:

Polymorphonuclear leukocytes increase glornerularalbumin permeability via hypohalous acid 1025

Li PKT, Poon ASY, Lai KN: Molecular genetics ofMHC class II alleles in Chinese patients with IgAnephropathy 185

Li PKT See Lai KN et al 862Li X-M See Nguyen G et a! 208Liaño F (abst) 558Light JA See Pereira BJG et a! 886Lima FB (abst) 1739Lima MDA (abst) 1740, 1740Lima MG (abst) 1738Lima NKC (abst) 1739Lima Verde EM (abst) 1745, 1745Limberg R, Koch C, Livni E, Shaharabani E, Shapira Z,

Falkenberg FW: Early recognition of rejections inkidney transplant recipients: Applying tests for kidney-derived urinary antigens 46:S-97

Linas SL See Sche!!ing JR et al 675Lindholrn B See HeimbUrger 0 et al 47:S-39Lindschau C See Hailer H et al 1653Liu L See Barajas L et a! 621Livesey JH (abst) 930Livni E See Limberg R et al 46:S-97Llibre J (abst) 573

Llopart L (abst) 564Liopart R (abst) 582Lloveras JJ (abst) 1242Lobão R (abst) 1753Lobão RRS (abst) 1751, 1751Lockwood CM See Esnault VLM et al 153

Lomani-Luakabwanga B (abst) 1247Lonergan MA (abst) 931, 937Loof I See Bornhard EM et al 46:S-60Lopes AA (abst) 1746

Lopes EPA (abst) 1748

Lopes LMV (abst) 1748, 1750Lopez de Novaies E (abst) 572Lopez GOmez JM (abst) 563Lopez Hidalgo J (abst) 583Lopez Hidaigo JL (abst) 560

Lopez J (abst) 561

118413971375245

1110157713301539

8551438260932

1778 Author Index Vol. 46

LOpez Menchero R (abst) 579, 580LOpez P See Bobadilla NA et al 773

Lopez R (abst) 580LOpez Ruiz JA (abst) 568Lopez-Menchero R (abst) 576, 576, 580LOpez-Novoa JM (abst) 560, 560, 564LOpez-Pedret J (abst) 574, 574Lorenzo V (abst) 560Losada A (abst) 582Losada M (abst) 560Lozano L (abst) 573Lu C-Y See Zhao J et al 717Lucas JCB (abst) 1749Lucena Robles M (abst) 584Lucena Robles MA (abst) 560Lucone PS (abst) 1750Luders C (abst) 1746, 1748Luft FC See Hailer H et a! 1653Luo M (abst) 929Lush DJ See Noble AR et al 1588Luskotoff DJ (abst) 934Ly H See Shankland SJ et al 430Lynn KL (abst) 921, 924, 924, 925, 934

MMacadam C (abst) 940, 940Macaulay H (abst) 942Macdonald GJ (abst) 933, 934Macdonald I (abst) 930Macdonald KJS (abst) 925Maceira B (abst) 560Machado MM (abst) 1744, 1752Macias WL See Clark WR et a! 1140Macica CM, Escalante BA, Conners MS, Ferreri NR:

TNF production by the medullary thick ascending limbof Henle's loop 113

Mackenzie HS See Zhang PL et al 414Mackenzie R See Topley N et al 900Mackman N (abst) 934MacLeod AM See McLay IS et al 1043Madeiro AP (abst) 1750Madrid ARF Study Group (abst) 564Maduell F (abst) 576, 576Magaldi Al (abst) 1742Magazine H See Noiri E et a! 1050Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G:

Autoantibodies against oxidatively-modified LDL inuremic patients undergoing dialysis 869

Mahiout A See Brunkhorst R et al 47:S-25Mahony IF (abst) 921, 923, 929, 933, 940, 940Makarious MM (abst) 934Makita N See Katoh T et al 341Mali WPT See Hené RI et al 1694Mali WPThM (abst) 1464Mallafrë JM (abst) 554, 554, 557, 565, 573Mallett C See Andreoli SP et a! 1100Malliaros J (abst) 927Malluche HH See Kurz P et al 855Malnic G (abst) 1742, 1744Malvestiti LF (abst) 1743

Mampaso F (abst) 559Manfredi SR (abst) 1747Manfro RC (abst) 1743

Maniar 5, Laouari D, Dechaux M, Motel V, Yvert J-P,Mathian B, Kleinknecht C: In vivo unaltered muscleprotein synthesis in experimental chronic metabolicacidosis 1705

Manjon M (abst) 556, 561, 569, 569, 574Mantha M (abst) 941Marcdn R (abst) 567, 575Marchi E See Gambaro G et al 797Marco A (abst) 568Marco MJ (abst) 561Marcondes M (abst). 1738, 1740, 1744, 1745, 1746, 1746, 1751,

1753Marigliano N (abst) 559, 572MarIn R (abst) 554, 554, 555, 582Marinides GN, Suchard Si, Mookerjee BK: Role of

thrombospondin in mesangial cell growth: Possibleexistence of an autocrine feedback growth circuit 350

Marone MMS (abst) 1743Marques VP (abst) 1751Marsden PA See Kester M et al 1404Marshall VC (abst) 932Marson 0 (abst) 1739Martin A (abst) 559, 581Martin AA (abst) 931, 932Martin AA See Hazel Si et al 58Martin C (abst) 561Martin J (abst) 570, 574, 586, 586, 586, 587Martin I, Knowlden J, Davies M, Williams ID:

Identification and independent regulation of humanmesangial cell metalloproteinases 877

Martin LC (abst) 1738Martin M (abst) 563, 564, 564, 565, 568, 582Martin R (abst) 567Martin SI See Esnault VLM et al 153Martinez A (abst) 561Martinez Alvarez A (abst) 568Martinez Ara I (abst) 558Martinez E (abst) 584Martinez F (abst) 556, 574Martinez Lanao J (abst) 577Martinez MD (abst) 575Martinez-Ara I See Diez II et a! 1387Martinez-O JC (abst) 581Martinez-Ocana IC (abst) 559Martini LA (abst) 1741Martin-Malo A (abst) 563, 575, 576Martin-Malo A See Bover I et al 310Marzec R See Schelling JR et a! 675Mason H See Yaqoob M et a! 46:S-101Massa A See Cianciulli P et a! 467Massad G See Mobley HLT et a! 46:S-129Masseroli M (abst) 560Massfelder T (abst) 1244Mat 0 See Abramowicz D et al 1596Mata M (abst) 576Mateos I (abst) 561Mathai M See McKinley Mi et a! 1479Mathews I (abst) 930Mathews ID (abst) 928Mathian B See Maniar S et al 1705Matos CM (abst) 1743Matouovic K See Chini CCS et a! 28Matsell DG, Delhanty PJD, Stepaniuk 0, Goodyer C,

Han VKM: Expression of insulin-like growth factorand binding protein genes during nephrogenesis 1030


Matsuda I See Nakazato H et a! 1307Matsuo 5, Nishikage H, Yoshida F, Nomura A,

Piddlesden SJ, Morgan BP: Role of CD59 inexperimental glomerulonephritis in rats 191

Matsuo S See Ichida S et al 89Matsuo T See Ono T et al 260Matsushima K See Wada T et al 455Matsushita DH (abst) 1739Matsuura T See Nakazato H et a! 1307Matteucci E, Giampietro 0: To store urinary enzymes:

How and how long? 46:S-58Mattingly MT, Brandt RR, Heublein DM, Wei C-M, Nir

A, Burnett JC Jr: Presence of C-type natriureticpeptide in human kidney and urine 744

Mattioli L (abst) 930Maymó R (abst) 573Maza A (abst) 568Mazuecos A (abst) 556, 562, 562, 562McAteer JA See Andreoli SP et al 1100McCauley JC (abst) 927McCausland J See Zhuo J et al 1483McClellan W See Farias MG et a! 1392McClellan W See Soucie JM et al 893McClelland P See Yaqoob M et al 46:S-101McCredie DA (abst) 928McCredie Margaret (abst) 925McDonald M (abst) 930McDougall JG (abst) 934McFarlane R (abst) 928, 930McGee 0 (abst) 923McKay NG See McLay JS et al 1043McKenna P (abst) 1468McKinley MJ, Evered M, Mathai M, Coghlan JP: Effects

of central losartan on plasma renin and centrallymediated natriuresis 1479

McKinley MJ See Oldfle!d BJ Ct al 1567McLay JS, Chatterjee P, Nicolson AG, Jardine AG,

McKay NG, Ralston SH, Grabowski P, Haites NE,MacLeod AM, Hawksworth GM: Nitric oxideproduction by human proximal tubular cells: A novelimmunomodulatory mechanism? 1043

McMahon MP (abst) 941McMahon SJ See Lea JP et al 647McPhee PD (abst) 930McWilliam BG (abst) 939Medina Cano MT (abst) 560, 583, 584Medina JOP (abst) 1750Medina-Alonso J See Garcia-Escribano C et a! 1611Megia M (abst) 556Melaragno CS (abst) 1750Mello YR (abst) 1745, 1746Melon S (abst) 582Ménard J See Yéniant M et a! 421Mendelsohn FAO See Zhuo J et al 1483Mendes RB (abst) 1738Mendez A (abst) 567, 568Méndez J See DIez JJ et al 1387Mendiluce A (abst) 570, 570Mendoza S See Bobadilla NA et a! 773Menè P, Teti A, Pugliese F, Cinotti GA: Calcium

release-activated calcium influx in cultured humanmesangial cells 122

Menéndez Fraga P (abst) 587, 587, 587Menéndez RodrIguez P (abst) 587Meneses JA (abst) 1740

Menezes EAM (abst) 1748, 1749Mentzel S (abst) 1467Mercure C See Reudelhuber TL et al 1522Merida FJ (abst) 568Merkle M See Boege F et al 46:S-93MertInez A (abst) 563Mesa L (abst) 563, 582Messa P, Vallone C, Mioni G, Geatti 0, Turrin D,

Passoni N, Cruciatti A: Direct in vivo assessment ofparathyroid hormone-calcium relation curve in renalpatients 1713

Messana JM See Young EW et al 1216Meyer TW See Baboolal K et a! 980Meyers CM, Kelly Ci: Immunoregulation and TGF-131

Suppression of a nephritogenic murine T cell clone ... 1295Meyrick B See Yoshioka T et al 405Miach P (abst) 940Miach PJ (abst) 939Michel P (abst) 1247Michelacci YM (abst) 1752Michelin L (abst) 1740MIDAS Study Group See Mistry CD et a! 496Miguel A (abst) 579, 580, 580, 580, 580, 580, 581Miguel Alonso JL (abst) 558, 566Miguel JL See DIez JJ et al 1387Mihatsch Mi See Young EW et al 1216Milanesi C See Gambaro 0 et a! 797Miller F See Conger JD et al 318Miller SB, Moulton M, O'Shea M, Hammerman MR:

Effects of IGF-I on renal function in end-stage chronicrenal failure 201

Miller TE (abst) 942Millos E (abst) 580Minguela I (abst) 583Minguez C (abst) 561Mion, Jr D (abst) 1740Mioni G See Messa P et al 1713Misael AM (abst) 1744, 1744Mistry CD, Gokal R, Peers E, MIDAS Study Group: A

randomized multicenter clinical trial comparingisosmolar Icodextrin with hyperosmolar glucosesolutions in CAPD 496

Mitch WE See Farias MG et al 1392Miura K See Kim S et a! 1346Miyake Y See Takahashi S et a! 1525Mizukoshi M See Chaki S et a! 1492Mobley HLT, Island MD, Massad G: Virulence

determinants of uropathogenic Escherichia coli andProteus mirabilis 46:S-129

Mobley HLT See Trifillis AL et a! 1083Mochizuki T (abst) 1461Modesto-Segonds A (abst) 1242Mohaupt MG, Elzie JL, Ahn KY, Clapp WL, Wilcox CS,

Kone BC: Differential expression and induction ofmRNAs encoding two inducible nitric oxide synthasesin rat kidney 653

Molero T (abst) 582Molina A (abst) 559, 567, 567Molitoris BA See Clark WR et a! 1140Mollison L (abst) 922, 928Monaco AP (abst) 1742Mondain JR (abst) 1245Mongay A (abst) 565Monier-Faugere M-C See Kurz P et a! 855Monnens L (abst) 1461

1780 Author Index: VoL 46

Monnens LAH (abst) 1467Monnens LAH See Knoers NVAM et al 170Monnier-Zeller V (abst) 1247Montanan G See Giovenali P et a! 1616Monteiro JL (abst) 1742Monteiro MC (abst) 1741Monteiro MCA (abst) 1750Montero A (abst) 560, 564Montes Delgado R (abst) 561Montes Puerta A (abst) 560, 584Montesano MAF (abst) 1745Montoro JA (abst) 586Montoyo C (abst) 562Mookerjee BK See Marinides UN et a! 350Moore R.J See Hazel SJ et a! 58Moore-Jarrett T See Yoshioka T et al 405Moorhead JF See Ong ACM et al 1315Morales JM (abst) 562, 562, 576Moran J (abst) 938, 938Morcos M, Hänsch GM, SchOnermark M, Ellwanger 5,

Harle M, HeckJ-Ostreicher B: Human glomerularmesangial cells express CD16 and may be stimulatedvia this receptor 1627

Moreau iF (abst) 1243Moreira SRS (abst) 1748Moreiras M (abst) 581Morel D (abst) 1243Moreno E (abst) 581Moreno I (abst) 579Moreno MV (abst) 572Moreso F, Serón D, Vitriá I, GrinyO JM, Colomé-Serra

FM, Pares N, Serra J: Quantification of interstitialchronic renal damage by means of texture analysis . . . . 1721

Morgan BP See Matsuo S et al 191

Morgan C (abst) 941

Morgan D (abst) 923Morgan I See Barrett BJ et al 1118Moriero E See Cannella G et al 1124Morin M-P (abst) 1244Morita A See Itoh Y et al 46:S-38Morris BJ, Smith DL, Law RE, Do YS, Shaw KJ, Hsueh

WA: Function of human renin proximal promoterDNA 1516

Morrissey I See Yanagisawa H et al 245Morton JJ See Whitworth CE et al 1528Motel V See Maniar S et al 1705Motellon I (abst) 561, 562, 565Moulton M See Miller SB et al 201Moura LA (abst) 1743, 1750Moussa M (abst) 1246Moyen U (abst) 1247Moysés RMA (abst) 1752Mu W (abst) 926Muhl H, Pfeilschifter J: Tetrahydrobiopterin is a limiting

factor of nitric oxide generation in intenleukin 1/3-stimulated rat glomerular mesangial cells 1302

Mujais SK See Gawaz MP et al 489Mukaida N See Wada T et al 455Muller G See Noiri E et a! 1050Mullins II See Whitworth CE ct al 1528Multicentric Group of Levante the (abst) 580Multilit Group (abst) 1740Mufloz D (abst) 570Munoz E (abst) 562, 565Munoz I (abst) 555

Muñoz M (abst) 574Munro FM (abst) 935Murakami K See Fukamizu A et al 1533Muros de Fuentes M (abst) 559Murphy BF (abst) 937Murr C See Fuchs D et al 46:S-8Murray-McIntosh RP (abst) 939, 939MusoESeeOnoTetal 260Mutti A See Fels LM et al 46:S-81

NNadaletto MAJ (abst) 1753Nader MAK (abst) 1747Nagai H See Ono T et al 260Nagashima A See Okuda S et al 1635Nahas AME See Shehata M et al 726Naito T See Wada T et al 455Nakamura H See Nakanishi K et al 1413Nakamura K See lenaga K et al 46:S-22Nakamura S See Carone FA et al 1368Nakanishi K, Yoshikawa N, lijima K, Kitagawa K,

Nakamura H, Ito H, Yoshioka K, Kagawa M, Sado Y:Immunohistochemical study of al-S chains of type IVcollagen in hereditary nephritis 1413

Nakano K See lenaga K et al 46:S-22Nakayama M See Okuda S et al 1635Nakazato H, Hattori 5, Ushijima T, Matsuura T,

Koitabashi Y, Takada T, Yoshioka K, Endo F,Matsuda I: Mutations in the COMAS gene in Alportsyndrome: A possible mutation in primordial germcells 1307

Nambi P See Gellai M et a! 1287Nankivell B (abst) 932Nankivell BJ (abst) 925, 937Nanra RS (abst) 933Navarro AntolIn I (abst) 559Navarro J (abst) 575Navanro JF (abst) 567Navas-Parejo A (abst) 556, 561, 569, 569, 574Naves DIaz M (abst) 587Naves ML (abst) 587Navis GI (abst) 1463, 1463Naya M (abst) 565N'Doye P (abst) 1242Neale TI (abst) 926, 937, 939, 939, 942Neau P (abst) 1245Nebreda I (abst) 567, 567Neubauer A See Topley N et a! 900Neubeck M See Fliser D et a! 482Neves FAR (abst) 1739Nevinny-Stickel M See Pfaller W et a! 46:S-68Newman DJ, Thakkar H, Edwards RU, Wilkie M, White

T, Grubb AO, Price CP: Serum cystatin C: Areplacement for creatinine as a biochemical marker ofGFR 46:S-20

Ng U (abst) 940Ng Y-Y (abst) 924Nguyen 0, Li X-M, Peraldi M-N, Zacharias U, Hagège

I, Rondeau E, Sraer I-D: Receptor binding anddegradation of urokinase-type plasminogen activatorby human mesangial cells 208

Nicastri AL (abst) 1753Nicholls K (abst) 922, 929Nicholls MG (abst) 934Nicolson AG See McLay IS et al 1043

Author Index: VoL 46 1781

Nielsen NV See Hoim J et a! 46:S-105Niemir Z (abst) 1744Nikolic-Paterson DJ (abst) 922, 926, 927Nilsson-Ehle P, Grubb A: New markers for the

determination of GFR: lohexol clearance and cystatinC serum concentration 46:S-17

Nilsson-Ehle P See Guder WG et a! 46:S-1Nir A See Mattingly MT et al 744Nishida SK (abst) 1748, 1749, 1750Nishikage H See Matsuo S et al 191Nivet H (abst) 1242Nobes MS (abst) 935Noble AR, Abu-Kishk RA, D'Aloia M-AE, Williams BC,

Lush DJ: Cyclic GMP-linked pathway for reninsecretion 1588

Noel L-H See Kokolina E et a! 177Nofer J-R See Tepel M et al 696Noiri E, Gailit J, Sheth D, Magazine H, Gurrath M,

Muller G, Kessler H, Goligorsky MS: Cyclic RGDpeptides ameliorate ischemic acute renal failure in rats. 1050

Nomura A See Matsuo S et al 191Noonan DM See Gambaro G et al 797Norman DJ See Pereira BJG et al 886Noronha IL (abst) 1744, 1745Nossal GJV (abst) 939Notkins AL See Ray PE et al 759Nouwen EJ (abst) 1462, 1470Nouwen EJ, de Broe ME: Human intestinal versus tissue

nonspecific alkaline phosphatase as complementaryurinary markers 46:S-43

Novillo R (abst) 559, 572Nowicki M See Ritz E et al 46:S-76Nowinski RJ See Kester M et al 1404Numata Y See Itoh Y et a! 46:S-38Nuflez J (abst) 570, 570, 577Nusbaum P See Kokolina E et al 177Nuyts GD (abst) 1461Nuyts GD See Fels LM et al 46:S-81Nzingoula S (abst) 1247

0Obengui YF (abst) 1247Oberbäumer I See Schafer K et al 134O'Brien R (abst) 929Ocharan J (abst) 568Oei HY (abst) 1469Ogata E See Kitaoka M et al 1110Ogg CS See Suassuna JHR et a! 443OhtaKSeeKimSetal 1346Ohta S See Wada T et al 455Ohyama K See Chaki S et al 1492Okada H See Ichida S et al 89Okada K See Tsuboi Y et al 237Okamoto MM (abst) 1739Okay Y (abst) 1746Okoshi K (abst) 1738Oksman F (abst) 1242Okuda S, Tamaki K, Ando T, Nagashima A, Nakayama

M, Fukuda K, Higashi H, Fujishima M: Increasedexpression of Nat'H exchanger in the injured renaltissues of focal glomeruloscierosis in rats 1635

Oldfield BJ, McKinley MJ: Distribution of Fos in ratbrain resulting from endogenously-generatedangiotensin II 1567

Oliva J (abst) 574

Oliva JA (abst) 554, 554, 557, 565, 573Olivares J (abst) 580, 580, 581Olivas JL (abst) 579Oliveira E (abst) 1750Oliveira J (abst) 1738Oliveira MJ (abst) 1739Oliveira PC (abst) 1749Oliveira VJ (abst) 1739Olmos A (abst) 563, 564, 564, 565, 568, 579, 579Omura T See Kim S et al 1346Ong ACM, Jowett TP, Moorhead JF, Owen JS: Human

high density lipoproteins stimulate endothelin-1release by cultured human renal proximal tubular cells. 1315

Ong CS (abst) 929, 933Ono T, Kanatsu K, Ueda 5, Matsuo T, Kuwahara T,

Onoe C, Nagai H, Muso E, Sasayama 5: Detection ofthe antigenicity of the d-dimer of cross linked fibrin inthe glomerulus by plasmin treatment (Technical Note). . 260

OnoeCSeeOnoTetal 260Oosterhuis W (abst) 1470Ooyama M See Hotta 0 et a! 46:S-117Oreopoulos D See Papanastasiou P et a! 216Oreopoulos DG See Yuan Z-Y et al 520Orero E (abst) 585, 585Orfao A (abst) 578, 578, 586, 586, 586, 587Orfila C (abst) 1245On M (abst) 1747, 1753Orii N (abst) 1744Orofino L (abst) 575Orte L (abst) 555, 555, 555, 558Ortiz MA (abst) 554, 557Ortuño J (abst) 555, 555, 555, 558, 559, 567, 575Ortuño T (abst) 556, 562O'Shea M See Miller SB et al 201Osmond DH See Daneman D et al 1154Osonio JM (abst) 583, 584Osuna A (abst) 583, 584Otero A (abst) 566Otero Glz A (abst) 566O'Valle Ravassa F (abst) 560, 584Ovnat A See Douvdevani A et a! 993Owen JS See Ong ACM et al 1315Owens JW See Ray PE et a! 759

PPacheco Silva A (abst) 1750Pacini S See Aterini S et al 461Page B (abst) 1244, 1244, 1244, 1244, 1245Painter DM (abst) 938Paixão ADO (abst) 1752Pallardó LM (abst) 585, 585, 585, 585, 585, 586Palomares L (abst) 581Palomares M (abst) 583Palop L (abst) 582Panarelli W See Cinillo M et a! 1133Pandak WM, Vlahcevic ZR, Heuman DM, Knieg RJ,

Hanna JD, Chan JCM: Post-transcriptional regulationof 3-hydroxy-3-methylglutaryl coenzyme: A reductaseand cholesterol 7cr-hydroxylase in rats with subtotalnephrectomy 358

Pankewycz OG, Guan J-X, Bolton WK, Gomez A,Benedict JF: Renal TGF-p regulation inspontaneously diabetic NOD mice with correlations inmesangial cells 748

Pantaleón AG (abst) 581

1782 Author Index VoL 46

Papa G See Cianciulli P et at 467Papanastasiou P, Grass L, Rodela H, Patrikarea A,

Oreopoulos D, Diamandis EP: Immunologicalquantification of advanced glycosylation end-productsin the serum of patients on hemodialysis or CA.PD 216

Papastoitsis G (abst) 577Paraiso V (abst) 574Pares N See Moreso F et a! 1721Parfrey P See Barrett BJ et al 1118Parini A (abst) 1243Parker C.! See Cheung AK et a! 1680Parker RA See Ikizier TA et al 830Parker RA See Ikizler TA et al 1178Parnham A (abst) 941Pascoal I (abst) 1746Pascual I (abst) 555, 555, 558Passerini P See Ponticelli C et al 595Passoni N See Messa P et a! 1713Pate! P See Clapp WL et al 627Patel SR, Ke HO, Vanholder R, Hsu CH: Inhibition of

nuclear uptake of calcitrio! receptor by uremicultrafiltrate 129

Pate! SR See Hsu CH et al 605Patino RO (abst) 1741Patrick AW See Yaqoob M et al 46:S-101Patrikarea A See Papanastasiou P et a! 216Paul M See Rettig R et al 1536Paula FJ (abst) 1745Pearse MJ (abst) 932Pedagogos £ (abst) 922Pedrena J (abst) 582Pedrera JD (abst) 572Peers £ See Mistry CD et al 496Pelagaggia M See Giovenali P et al 1616Pelegrina Jimenez A (abst) 583Pefla J (abst) 575Penna D (abst) 1748Pennock Y (abst) 940Peral V (abst) 556, 571, 571Peraldi M-N See Nguyen U et a! 208Percärio S (abst) 1745Percheron A (abst) 1244, 1244Perdomo M (abst) 582Pereira AB (abst) 1748, 1748, 1749, 1750Pereira BIG, Wright TL, Schmid CH, Bryan CF, Cheung

RC, Cooper ES, Hsu H, Heyn-Lamb R, Light IA,Norman DJ, Van Thiel DH, Werner BG, Wright CE,Levey AS: Screening and confirmatory testing ofcadaver organ donors for hepatitis C virus infection: AU.S. National Collaborative Study 886

Pereira LC (abst) 1738Pereira RC (abst) 1744, 1744, 1752Perez Diaz V (abst) 570Perez I See Boutard V et al 1280Perez MVA (abst) 1740Perez Parajon J (abst) 587PérezR(abst) 581Perez-GarcIa R (abst) 579, 579, 579Perez-Oliva-Diaz JF (abst) 1246Pergande M See Fels LM et al 46:S-81Pens X (abst) 564Perrella MA See Tan M-S et al 690Perrett D (abst) 941Perrone A See Fern C et a! 780Perrone HC (abst) 1743, 1746

Pesarini A See Gambaro G et al 797Pestana JO (abst) 1741Pestana JOM (abst) 1742, 1743, 1750, 1751Petersen MM See Topley N et al 900Petrie R, Ford-Hutchinson AW: Elevated cysteiny!

leukotriene excretion in experimentalglomerulonephritis 1322

Peyronnet P (abst) 1242Pfaller W, Thorwartl U, Nevinny-Stickel M, Kral! M,

Schober M, Joannidis M, Hobisch A: Clinical value offructose 1, 6 bisphosphatase in monitoring renalproximal tubular injury 46:S-68

Pfeilschifter J See MUhl H et al 1302Pham C (abst) 940Pham P See Zhao J et al 717Philippe C See Boutard V et a! 1280Phillips I See Yoshida H et al 1505Phillips MI, Wielbo D, Gyurko R: Antisense inhibition

of hypertension: A new strategy for renin-angiotensincandidate genes 1554

Piccoli A, Rossi B, Pillon L, Bucciante U: A new methodfor monitoring body fluid variation by bioimpedanceanalysis: The RXc graph (Technical Note) 534

Picken M See Griffin KA et al 1010Piddlesden 5.! See Matsuo S et al 191

Pidgeon GB (abst) 934Piera C (abst) 568Piera L (abst) 556, 563, 564, 564, 565, 568, 579, 579Piers DB (abst) 1472Pignatari A (abst) 1738Pilar Simeón C (abst) 563Pillon L See Piccoli A et al 534Pinheiro ME (abst) 1750Pinho NB (abst) 1738Placier S See Zhao J et a! 717Plagaro ME (abst) 567, 567Plaza C (abst) 582PolenakoviC M See Carone FA et a! 1368Polihronis M (abst) 937Pollock C (abst) 922, 923Pollock CA (abst) 921, 929, 933, 935, 936, 940, 940Pommer S (abst) 1745Ponticelli C, Passerini P: Treatment of the nephrotic

syndrome associated with primary glomerulonephritis. .. 595Pontremoli R, Zerbini 0, Rivera A, Canessa M: Insulin

activation of red blood cell Na/H exchangedecreases the affinity of sodium sites 365

Poon ASY See Li PKT et al 185Port FK Morbidity and mortality in dialysis patients

(Nephro!ogy Forum) 1728Porter JG (abst) 1742Porter 5 (abst) 941Postma CT (abst) 1469Poston L See Woolfson RG et a! 297Potaux L (abst) 1243Pou JM (abst) 554, 557Pourtein M (abst) 1243Poux JM (abst) 1246Poveda R (abst) 555Powell HR (abst) 921Power DA (abst) 937Praddaude F (abst) 1246Pradier 0 See Abramowicz D et a! 1596Prado EBA (abst) 1745, 1753Prado MJBA (abst) 1753


Praga M (abst) 556, 562, 562, 562, 562, 576, 576Pratt RE See Sasamura H et al 1499Preud'homme J-L, Aucouturier P, Touchard G, Striker

L, Khamlichi AA, Rocca A, Denoroy L, Cogné M:Monoclonal immunoglobulin deposition disease(Randall type) Relationship with structuralabnormalities of immunoglobulin chains (EditorialReview) 965

Price A (abst) 933Price CP See Newman Di et al 46:S-20Price RG, Taylor SA, Crutcher E: Assay of laminin

fragments in the assessment of renal disease 46:S-25Price RG See Fels LM et al 46:S-81Prins FA (abst) 1469Prodjosudjadi W See Florijn KW et al 252Prompt CA (abst) 1743, 1747Provoost AP (abst) 1464Provoost AP See Simons JL et al 396Pugliese F See Menè P et al 122

Pugsley D (abst) 930Puig N (abst) 586Pulido F (abst) 562Pullen M See Gellai M et al 1287Purroy A (abst) 563, 582Pussell BA (abst) 933

QQuass P See Hailer H et al 1653Quereda C (abst) 555, 555, 558Quezado ZMN (abst) 1745Quintero Quintero M (abst) 559Quiroga S (abst) 556Quiros A (abst) 569Quiros E (abst) 569

RRabelink A.J (abst) 1469Rabelink AJ: Thrombosis and hemostasis in renal

disease 287Rabelink TJ, Kaasjager KAH, Boer P, Stroes EG, Braam

B, Koomans HA: Effects of endothelin-1 on renalfunction in humans: Implications for physiology andpathophysiology 376

Rabelink Ti See ioles iA et al 97Rabello TVF (abst) 1747Radda G (abst) 921Radnik R See Kreisberg ii et al 1019Radnik RA See Kreisberg JI et al 105Raftery AT See Shehata M et al 726Raggi PP (abst) 1740Raij L See Westberg G et al 711Rainone S (abst) 922Raizada M See Sernia C et al 1574Rajabalendran N (abst) 928Rajagopalan B (abst) 921Ralston SH See McLay JS et al 1043Rama H (abst) 555Ramée M-P See Simon P et al 1192Ramirez de Arellano M (abst) 575Ramirez iA See Goodman WG et al 1160RamIrez Tortosa C (abst) 583, 584Ramirez-Arellano M (abst) 575, 575Ramla D See Reudelhuber TL et al 1522Ramos B (abst) 572Ramos G (abst) 568

Ranger-rogez S (abst) 1246Ranieri E See Gesualdo L et al 1002Rapoport J See Douvdevani A et al 993Rappaport J, Kopp JB, Klotman PE: Host virus

interactions and the molecular regulation of HIV-1:Role in the pathogenesis of HIV-associatednephropathy (Editorial Review) 16

Raugi Gi See Abrass CK et al 613

Ray CD (abst) 931Ray PE, Bruggeman LA, Weeks BS, Kopp iB, Bryant

iL, Owens iW, Notkins AL, Klotman PE: bFGF andits low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice 759

Raya E (abst) 574Razvickas CV (abst) 1745, 1748, 1752Re U See Gambaro G et al 797Reaich D See Graham KA et al 47:S-47Recio F, Villamii F: Charge selectivity and urine amylase

isoenzymes 46:S-89Reddington JC See Schmitz PG et al 1184Reddy S (abst) 936Reed EE (abst) 927Reeders S (abst) 1461Regenbogen C See Hofmann W et al 46:S-111Reichert LJM (abst) 1465Reis LM (abst) 1744, 1744, 1752Remón C (abst) 561Rennke HG See Simons iL et al 396Rettig R, BUch M, Gerstberger R, Schnatterbeck P, Paul

M: Effects of kidney transplantation on the renin-angiotensin systems of the recipients 1536

Reudelhuber TL, Ramla D, Chiu L, Mercure C, SeidahNG: Proteolytic processing of human prorenin in renaland non-renal tissues 1522

Revelles MarIn F (abst) 584Revert L (abst) 574, 574Rial Rodriguez iM (abst) 559Ribacchi R See Giovenali P et al 1616Ribeiro A (abst) 1740Ribeiro AB (abst) 1739, 1740Ribeiro L (abst) 1745Richards AM (abst) 934, 936Riegger G See Schricker K et al 1539Riegger GAJ See Kramer BK et al 1577Rifle G (abst) 1247Rigal-Huguet F (abst) 1242Rincon B (abst) 561, 562, 565Riñón M (abst) 583Ripoche P (abst) 1245Ritthaler T See Kramer BK et al 1577Ritz E (abst) 1744Ritz E, Nowicki M, Fliser D, Homer D, Klimm H-P:

Proteinuria and hypertension 46:S-76Ritz E See Fliser D et al 482Ritz E See Wagner i et al 1542Rivas-Cabanero L (abst) 560, 564Rivera A See Pontremoli R et al 365Rivera F (abst) 574Rivera M (abst) 555, 555, 559Robertson MC (abst) 929Robertson MC See Corboy J et al 1147Robertson MR (abst) 933Robinette JB See Conger JD et al 318Robson RA (abst) 921, 924, 924, 925Roca R (abst) 563, 564


Rocca A See Preud'homme J-L et al 965Rocha RB (abst) 1746Roche PJ, Eddie LW, Coghian JP: Characterization of a

mutant type-i angiotensin II receptor 1580Rochera A (abst) 585, 585, 585, 586Rodá M (abst) 582Rodela H See Papanastasiou P et a! 216Rodela H See Yuan Z-Y et al 520Rodeles M (abst) 567Rodicio JL (abst) 556, 562, 562, 562, 576Rodrigo A (abst) 567, 567RodrIguez A (abst) 560Rodriguez Arzadun J (abst) 568Rodriguez C (abst) 556, 571, 571Rodriguez Gil J (abst) 584Rodriguez JA (abst) 564, 565, 579, 579Rodriguez JC (abst) 582Rodriguez M (abst) 563, 581Rodriguez M See Bover J et a! 310Rodriguez P (abst) 556Rodriguez Rodriguez I (abst) 559Rodriguez-Barbero A (abst) 560, 564Rodriguez-Commes J, Isales C, Kaighati L, Gasalla-

Herraiz J, Hayslett JP: Mechanism of insulin-stimulated electrogenic sodium transport 666

Rodriguez-LOpez AM (abst) 560Rodriguez-Puyol D See Garcia-Escribano C et al 1611Rodriguez-Puyol M See Garcia-Escribano C et at 1611Roels H See Fels LM et a! 46:5-81Rohde RD See Hebert LA et al 1688Rolla D See Cannella G et a! 1124Romanella M (abst) 932Romão, Jr JE (abst) 1743, 1746, 1746Romero R (abst) 558, 581, 582Ronco C, Bosch JP, Lew SQ, Feriani M, Chiaramonte 5,

Conz P, Brendolan A, La Greca G: Adequacy ofcontinuous ambulatory peritoneal dialysis: Comparisonwith other dialysis techniques 47:S-18

Rondeau E See Nguyen G et al 208Rong P, Berka JL, Kelly Di, Alcorn D, Skinner SL:

Renin processing and secretion in adrenal and retinaof transgenic (m REN-2)27 rats 1583

Ros F (abst) 585, 585Rose UM, Bindels RiM, Jansen JWCM, van Os CH:

Effects of Ca2 channel blockers, low Ca2 mediumand glycine on cell Ca2 and injury in anoxic rabbitproximal tubules 223

RosellO J See Fels LM et al 46:S-81Rosenberg ME See Shultz PJ et al 683Rosenthal-Allieri MA (abst) 1245Ross BD See Videen iS et al 46:S-i22Ross M (abst) 922Rossi B See Piccoli A et at 534Rostaing L (abst) 1242Roth P See Kurz P et al 855Rothlein R See Andreoli SP et al 1100Roussaud F (abst) 582Rousseau B (abst) 1245Rovin BH, Tan LC: Role of protein kinase pathways in

IL-i-induced chemoattractant expression by humanmesangial cells 1059

Rovin BH See Cosio FG et ai 986Rowe DiP, Twyman S: Diagnostic strategy to monitor

diabetic nephropathy 46:S-109Rowshani T (abst) 1460

Roy LP (abst) 927, 935, 940Ruben A (abst) 583Rubio C (abst) 570, 570, 570RUckle H See Boege F et al 46:5-93Rufino M (abst) 560Ruger B (abst) 926, 937RUger BM (abst) 939, 942Ruggiero M See Aterini S et al 461Ruilope LM (abst) 562Ruiz C (abst) 565, 565Ruiz M (abst) 581, 582Ruiz P (abst) 556, 564, 564Russell RG See Trihhlis AL et a! 1083Ruzany F (abst) 1751, 1752Ryan GB (abst) 931

SSabater J (abst) 555, 555Sabbaga E (abst).... 1738, 1743, 1743, 1744, 1744, 1745, 1746,

1746, 1748, 1751, 1752Sader H (abst) 1738Sado Y See Nakanishi K et al 1413Sahai A, Fadda GZ, Sandier RS, Tannen RL: PGF2a

activation of Na/H antiporter and ammoniagenesis inparent/variant LLC-PK1 cells 1069

Saikumar P See Kreisberg ii et a! 105Saito T See Tsuboi Y et al 237Saitovich D (abst) 1743Salati MI (abst) 1739Salazar D (abst) 1461Saldanha LB (abst) 1743, 1748Saleh A (abst) 569Salinas-Madrigal L See Schmitz PG et al 1184Salipan Moore N (abst) 936Saltissi D (abst) 923, 924, 941Salusky lB See Goodman WG et a! 1160Salvadori M See Aterini S et al 461Salzano FM (abst) 1746Sampaio JC (abst) 1751San Miguel J (abst) 586Sanchez E (abst) 567, 567Sanchez J (abst) 561, 569, 585, 585, 585, 585, 586Sanchez JM (abst) 559Sanchez 0 (abst) 559, 572Sanchez P (abst) 585, 585, 585, 585, 586Sanchez Perez P (abst) 585Sanchez Plumed J (abst) 585Sanchez R (abst) 556, 562, 562, 576, 576Sanchez Tomero JA (abst) 562Sanchez-Tomero J (abst) 565Sanchez-Tomero JA (abst) 561Sandberg K See Hunyady L et a! 1496Sanders HM (abst) 1751Sandier RS See Sahai A et a! 1069Sands JM See Lea JP et a! 647Santana, Jr AM (abst) 1750Santos AA (abst) 1744Santos EA (abst) 1739, 1739Santos MFF (abst) 1748Santos OFP (abst) 1748Santos Perez JL (abst) 584Santos SFF (abst) 1751Santucci A See Fern C et at 780Sanz Guajardo D (abst) 567Sanz Moreno C (abst) 567, 569


Sanz P (abst) 561, 562, 565Saralegui I (abst) 568Sarrias X (abst) 555Sarrión A (abst) 585Saruta T See Yoshida H et al 1505Sasamura H, Dzau VJ, Pratt RE: Desensitization of

angiotensin receptor function 1499Sasayama S See Ono T et a! 260Sastre J See DIez JJ et al 1387Satriano J See Shan Z et a! 388Saussine C (abst) 1244Sauvage D (abst) 923Savige J (abst) 938, 939, 939, 940Savin VJ, Johnson RJ, Couser WG: C5b-9 increases

albumin permeability of isolated glomeruli in vitro 382Savin VJ See Li JZ et al 1025Sawada H (abst) 937Saxena PR (abst) 1460Schaefer L, Gilge U, Heidland A, Schaefer RM: Urinary

excretion of cathepsin B and cystatins as parameters oftubular damage 46:S-64

Schaefer RM See Schaefer L et al 46:S-64Schafer K, Gretz N, Bader M, Oberbäumer I, Eckardt

K-U, Kriz W, Bachmann 5: Characterization of theHan:SPRD rat model for hereditary polycystic kidneydisease 134

Schalekamp MA (abst) 1460Schalekamp MADH (abst) 1460, 1469Schalkwijk J (abst) 1462Scheek LM See Joles JA et al 97Schellekens PTA See Bemelman FJ et al 1674Schellekens PThA (abst) 1465, 1468Schelling JR, DeLuca DJ, Konieczkowski M, Marzec R,

Sedor JR, Dubyak GR, Linas SL: Glucocorticoiduncoupling of angiotensin TI-dependent phospholipaseC activation in rat vascular smooth muscle cells 675

Schena FP See Gesualdo L et al 1002Scherberich JE, Wolf G: Disintegration and recovery of

kidney membrane proteins: Consequence of acute andchronic renal failure 46:S-52

Schiller B (abst) 938, 938Schlondorff D See Shan Z et a! 388Schmid CH See Pereira BJG et al 886Schmidt B See Gawaz MP et a! 489Schmitz PG, Krupa SM, Lane PH, Reddington JC,

Salinas-Madrigal L: Acquired essential fatty aciddepletion in the remnant kidney: Amelioration withU-63557A 1184

Schnatterbeck P See Rettig R et al 1536Schober M See Pfaller W et al 46:S-68Schoeller DA See Ho LT et al 1438Schoemaker RC (abst) 1468Scholey JW See Shankland SJ et a! 430Schönermark M See Morcos M et a! 1627Schor N (abst). 1738, 1741, 1741, 1741, 1741, 1743, 1745, 1748,

1750, 1752, 1752, 1752Schrama E (abst) 1471Schramek H, Wang Y, Konieczkowski M, Simonson MS,

Dunn Mi: Endothelin-1 stimulates cytosolicphospholipase A2 activity and gene expression in ratglomerular mesangial cells 1644

Schricker K, Hamann M, Kaissling B, Kurtz A: Renalautocoids are involved in the stimulation on reningene expression by low perfusion pressure 1330

Schricker K, Holmer S, Kramer BK, Riegger G, KurtzA: Control of renin gene expression in 2 kidney-i cliprats 1539

Schricker K See Kramer BK et a! 1577Schrier RW (abst) 1747SchrOder C (abst) 1461Schroeijers WEM See van den Dobbelsteen MEA et al ... 512Schröter M See Fliser D et a! 482Schui!ing GA (abst) 1469, 1471Schulman G See Ikizler TA et al 1178Schultz MF See Conger JD et al 318Schurek H-J: Mechanisms of glomeru!ar proteinuria and

hematuria 46:S-12Schurgers M (abst) 1470Schved J-F See Gris J-C et a! 807Seccia M See Maggi E et a! 869Sedmak DD See Cosio FG et al 471Sedor JR See Schelling JR et a! 675

Segarra A (abst) 556, 563, 564, 579Segre GV See Goodman WG et a! 1160

Segreto HRC (abst) 1745

Seguro AC (abst) 1742, 1747, 1747Seidah NG See Reudeihuber TL et a! 1522Selgas R See DIez ii et al 1387

Sequeira DMC (abst) 1739

Serapião M (abst) 1750Sernia C, Zeng T, Shinke! T, Kerr D, Raizada M:

Interactions of glucorcorticoids and cyclic AMP in thetissue-specific regulation of angiotensinogen 1574

Sernia C See Darby IA et a! 1557Serón D (abst) 584Serón D See Moreso F et a! 1721Serra J See Moreso F et al 1721Serrano M (abst) 587Serrano P (abst) 575Sesso A (abst) 1753Sesso R (abst) 1738, 1743, 1748Sesso RC (abst) 1747Shaharabani E See Limberg R et a! 46:S-97Shan Z, Tan D, Satriano J, Si!biger S. Schlondorff D:

Intracellular glutathione influences collagen generationby mesangial cells 388

Shand B! (abst) 924, 924Shankland SJ, Scholey JW, Ly H, Thai K: Expression of

transforming growth factor-Ill during diabetic renalhypertrophy 430

Shapira Z See Limberg R et a! 46:S-97Sharma R See Li iZ et al 1025Shaw GS See Clapp WL et al 627Shaw KJ See Morris Bi et a! 1516Shehan BP (abst) 931Shehata M, Nahas AME, Barkworth E, Cope GH,

Raftery AT: Increased platelet-derived growth factorin the kidneys of cyclosporin-treated rats 726

Sheth D See Noiri E et a! 1050Shibata T See Cosio FG et a! 986Shimada S See Fukamizu A et al 1533Shimamura T See Duncan MK et a! 324Shin S-i See Tan M-S et al 690Shinkel T See Sernia C et a! 1574Shiota N See Fukamizu A et a! 1533Shirai H See Chaki S et a! 1492Short AK See Esnault VLM et a! 153


Shultz PJ, Archer SL, Rosenberg ME: Inducible nitricoxide synthase mRNA and activity in glomerularmesangial cells 683

Shultz PJ See Tolins JP et al 230Shultz PJ See Westberg G et al 711Sigmund C See Catanzaro DF et al 1513SigUenza F (abst) 576, 576Silbiger S See Shan Z et al 388Silva AEB (abst) 1748Silva MS (abst) 1748, 1749, 1750Silva, Jr HT (abst) 1750Simeoni U (abst) 1244Simmonds M (abst) 936Simon N, Couroucé A-M, Lemarrec N, Trépo C,

Ducamp S: A twelve year natural history of hepatitis Cvirus infection in hemodialyzed patients 504

Simon F, Ramée M-P, Autuly V, Laruelle E, CharasseC, Cam G, Ang KS: Epidemiology of primaryglomerular diseases in a French region Variationsaccording to period and age 1192

Simons JL, Provoost AP, Anderson 5, Rennke HG, TroyJL, Brenner BM: Modulation of glomerularhypertension defines susceptibility to progressiveglomerular injury 396

Simonson MS See Schramek H et al 1644Sinclair R (abst) 939Sixma J (abst) 1469Sizeland P (abst) 928Skehel JM See Esnault VLM et al 153Skinner M (abst) 577Skinner SL See Rong P et a! 1583Smeets H (abst) 1461Smith AR (abst) 921, 930Smith DL See Morris BJ et a! 1516Smith KGC (abst) 939Smith PJ (abst) 926Soares VA (abst) 1746Sobrado J (abst) 581Sochett EB See Daneman D et a! 1154Sole M (abst) 577Soler C (abst) 1242Soler J (abst) 558, 573Solis C (abst) 566Sollecito D See Cianciulli P et al 467Soriano C (abst) 584Sorrentino F See Cianciulli P et al 467Sotornik I (abst) 1461Soucie JM, Thun MJ, Coates Ri, McClellan W, Austin

H: Demographic and geographic variability of kidneystones in the United States 893

Soucie JM See Farias MG et al 1392Soulilou J-P: Relevant targets for therapy with

monoclonal antibodies in allograft transplantation(Nephrology Forum) 540

Souza ERM (abst) 1741Spanish Registry of Glomerulonephritis (REGN) (abst). . . 564Spencer K (abst) 931Spicer D See Abrass CK et al 613Spiegel DM See Ho LT et al 1438Sprague SM, Krieger NS, Bushinsky DA: Greater

inhibition of in vitro bone mineralization withmetabolic than respiratory acidosis 1199

Sraer J-D See Nguyen G et al 208Stabile C (abst) 1739Stabile Neto C (abst) 1753

Stahl-Hennig C See Fuchs D et al 46:S-8Stamler J See Cirillo M et al 1133Stein A (abst) 933Stein H (abst) 1744, 1745Stein-Oakley A (abst) 932Stein-Oakley AN (abst) 933Stein-Oakley AN, Tzanidis A, Fuller PJ, Jablonski P,

Thomson NM: Expression and distribution ofepidermal growth factor in acute and chronic renalallograft rejection 1204

Stepaniuk 0 See Matsell DG et al 1030Sterk LT (abst) 1464Stevenson A See Yaqoob M et a! 46:S-101Stewart JH (abst) 925Stolte H See Fels LM et al 46:S-81Stowasser M See Klemm SA et al 1591Striker L See Preud'homme J-L et al 965Stroes EG See Rabelink TJ et al 376Struijk DG (abst) 1460, 1467, 1471Struijk DG See Imholz ALT et al 333Struijk DG See Krediet RT et a! 47:S-7Struijk DO See Zemel D et a! 1422Studer RK, Craven PA, DeRubertis FR: Thromboxane

stimulation of mesangial cell fibronectin synthesis issignalled by protein kinase C and modulated by cGMP .. 1074

Study Group The (abst) 1465

Styles P (abst) 921Stylianou E See Topley N et a! 900Suassuna JHR, Das Neves FC, Hartley RB, Ogg CS,

Cameron iS: Immunohistochemical studies of theperitoneal membrane and infiltrating cells in normalsubjects and in patients on CAPD 443

Suc JM (abst) 1242, 1242, 1245Suchard SJ See Marinides GN et a! 350Sugiyama F See Fukamizu A et al 1533Sun J See Catanzaro DF et al 1513Sunar-Akbasak B See Aguilera G et al 973Surachno J See Bemelman FJ et a! 1674Surachno S (abst) 1465, 1468Suria M (abst) 573Surita RJS (abst) 1749Surquin M See Abramowicz D et al 1596Sutherland WH See Corboy J et a! 1147Sutherland WHF (abst) 929Swanson ON See Harding JW et a! 1510

TTabernero J (abst) 586, 586Tabernero JM (abst) 577, 577, 578, 578, 578, 586, 587Tack I (abst) 1246Taguma Y See Hotta 0 et a! 46:S-117Takada T See Nakazato H et a! 1307Takahashi C (abst) 1752Takahashi K See Kambayashi Y et al 1502Takahashi S. Inoue H, Fukui K, Miyake Y: Structure

and function of renin binding protein 1525Takeda M See Yoshioka T et a! 405Tallón S (abst) 563, 581Tamaki K See Okuda S et a! 1635Tamsma iT (abst) 1460Tan D See Shan Z et a! 388Tan LC See Rovin BH et a! 1059


Tan M-S, Tsai J-C, Lee Y-J, Chen H-C, Shin S-J, LaiY-H, Perretla MA, Bianchi C, Higashiyama S, EndegeW, Lee M-E, Tsai JH: Induction of heparin-bindingepidermal growth factor-like growth factor mRNA byprotein kinase C activators 690

Tange M (abst) 932Tani M See Chaki S et a! 1492Tannen RL See Sahai A et a! 1069Tapia E See Bobadilla NA et at 773Tarlinton DM (abst) 939Tasso JRP (abst) 1749Taupin JL (abst) 1243Tavares A (abst) 1739, 1740Tay Y-C (abst) 932, 937Taylor D (abst) 921Taylor SA See Fels LM et a! 46:S-81Taylor SA See Price RG et a! 46:S-25Teixeira MCB (abst) 1743Teixeira VPC (abst) 1745Teixidó J (abst) 559, 581, 582Tejada F (abst) 582Tejedor A (abst) 561, 563ten Berge IJM See Bemelman FJ et a! 1674ten Berge RJM (abst) 1465, 1468Tenreiro C (abst) 582Teodósio MR (abst) 1750Tepel M, Heidenreich 5, Zhu Z, Walter M, Nofer J-R,

Zidek W: Captopril inhibits the agonist-inducedincrease of cytosolic free Ca2 in glomerularmesangial cells 696

ter Wee PM (abst) 1460, 1471Terroba C (abst) 567, 567Teruel J (abst) 567, 575Tervaert JWC See Kallenberg CGM et at 1

Tesch G (abst) 922Teti A See Menè P et at 122Thai K See Shankland SJ et al 430Thakkar H See Newman DJ et at 46:S-20Thatcher G (abst) 941Thervet E (abst) 1244, 1244, 1245Thibault G (abst) 1242Thielemans NO See Bernard AM et at 46:S-34Thien TABM (abst) 1469Thomas AC (abst) 940Thomas G (abst) 940Thomas M (abst) 941Thomé DC (abst) 1746Thompson C (abst) 921Thomson NM (abst) 925, 932, 933, 942Thomson NM See Stein-Oakley AN et al 1204Thorogood J (abst) 1464Thorwart! U See Pfal!er W et a! 46:S-68Thun MJ See Soucie JM et al 893Tian Y See Hunyady L et al 1496Ticchioni M (abst) 1245Timmerman JJ (abst) 1468Tinucci T (abst) 1740Tipping PG (abst) 926, 927, 934, 942, 942Tipping PG, Huang XR, Berndt MC, Ho!dsworth SR: A

role for P setectin in complement-independentneutrophil-mediated glomerular injuly 79

Tipping PG See Huang XR et a! 69Tolchin N See Hebert LA et al 1688Tolins JP, Shultz PJ: Endogenous nitric oxide synthesis

determines sensitivity to the pressor effect of salt 230

Tome LA (abst) 1747Tome R (abst) 556, 571, 571Tomosugi N See Wada T et al 455Tonato EJ (abst) 1751Topley N, Petersen MM, Mackenzie R, Neubauer A,

Stylianou E, Kaever V, Davies M, Coles GA, JOrres A,Williams JD: Human peritoneal mesothelial cellprostaglandin synthesis: Induction of cyclooxygenasemRNA by peritoneal macrophage-derived cytokines.... 900

Topley N, Williams JD: Role of the peritonealmembrane in the control of inflammation in theperitoneal cavity 47:S-71

Topley N See Gahl GM et a! 47:S-1Toporovski J (abst) 1743, 1745, 1746Tomero F See Herrero JA et al 1167Torralbo A See Herrero JA et at 1167Torras J (abst) 584Torrealday H (abst) 572Torregrosa V (abst) 574Torrente J See Herrero JA et at 1167Torres A (abst) 560, 563Touchard G (abst) 1242Touchard G See Preud'homme J-L et at 965Toupance 0 (abst) 1242Tovar JL (abst) 556, 563Towner RA (abst) 936, 936Tran-Van T (abst) 1246Traver JA (abst) 557, 561, 562, 565Trecco SM (abst) 1744Trépo C See Simon N et a! 504Trifillis AL, Donnenberg MS, Cui X, Russell RG, Utsalo

SJ, Mobley HLT, Warren JW: Binding to and killingof human renal epithelial cells by hemolytic P-fimbriated E. coli 1083

Trinidad P See Bover J et at 310Trobo JI See Herrero JA et at 1167Troy JL See Simons JL et a! 396Troy JL See Zhang PL et a! 414Trudet M See De Paepe ME et al 1337Tsai J-C See Tan M-S et a! 690Tsai JH See Tan M-S et al 690Tsitibary EC See Anderson SS et at 1359Tsuboi Y, Ishikawa S-e, Fujisawa 0, Okada K, Saito T:

Therapeutic efficacy of the non-peptide AVPantagonist OPC-31260 in cirrhotic rats 237

Tucci PJF (abst) 1738Tucker M See Barajas L et at 621Tumlin JA See Lea JP et a! 647Tunny TJ See Klemm SA et at 1591Turrin D See Messa P et at 1713Twyman S See Rowe DJF et at 46:S-109Tzanidis A (abst) 933Tzanidis A See Stein-Oakley AN et at 1204Tzanno-Martins C (abst) 1744, 1751

UUeda S See Ono T et a! 260Ulla M (abst) 570Unwin R, Capasso G, Giebisch G: Potassium and

sodium transport along the loop of Henle: Effects ofaltered dietary potassium intake 1092

Urena P (abst) 1244Uriet B (abst) 566Ushijima T See Nakazato H et at 1307Utsalo SJ See Trifiltis AL et al 1083


VVaccari 0 (abst) 572Vaisbich MH (abst) 1750Valcárcel F (abst) 578Valderrábano F (abst) 561, 563, 579, 579, 579Vallone C See Messa P et al 1713Valverde V (abst) 571, 572van Bockel HH (abst) 1465van Bree JB (abst) 1468van Dam W See Florijn KW et a! 252van den Dobbeisteen MEA, van der Woude FJ,

Schroeijers WEM, van den Wall Bake AWL, van EsLA, Daha MR: Binding of dimeric and polymeric IgAto rat renal mesangial cells enhances the release ofinterleukin 6 512

van den Heuvel L (abst) 1461van den Ouweland AMW See Knoers NVAM et al 170van den Wall Bake AL (abst) 1470van den Wall Bake AWL See van den Dobbelsteen

MEAetal 512van der Born J (abst) 1460van der Groen G (abst) 1468van der Grond J (abst) 1464van der Grond J See Hené RJ et al 1694van der Woude FJ (abst) . . 1460, 1462, 1464, 1465, 1468, 1468,

1471, 1472van der Woude FJ See van den Dobbeisteen MEA et al . . 512van Det NF (abst) 1460van Diepen F (abst) 1465van Diepen FNJ (abst) 1468van Dorp WT (abst) 1465van Es LA (abst) . . . . 1462, 1464, 1465, 1468, 1470, 1471, 1472van Es LA See Florijn KW et al 252van Es LA See van den Dobbelsteen MEA et al 512Van Eslande L (abst) 1245van Gijlswijk-Janssen DJ (abst) 1468van Gompel APM (abst) 1462van Goor H (abst) 1467van Issel H (abst) 1470van Jaarsveld BC (abst) 1469van Landeghem GF (abst) 1470van Olden RW See Krediet RT et al 47:S-7van Oost BA (abst) 1467van Oost BA See Knoers NVAM et a! 170van Os CH (abst) 1459, 1467van Os CH See Rose UM et al 223van Paassen P (abst) 1463van Renen Mi (abst) 931, 932van Rooij J (abst) 1468van Saase JLCM (abst) 1464, 1465, 1470, 1472van Saase JLCM See Florijn KW et al 252van Son JPHF (abst) 1467Van Thiel DH See Pereira BJG et al 886van To! A (abst) 1463van To! A See ioles JA et al 97van Wimersma Greidanus TjB (abst) 1470Vande Walle JGJ (abst) 1470Vanherweghem J-L See Abramowicz D et al 1596Vanholder R See Hsu CH et al 605Vanholder R See Patel SR et al 129Van RC See Hanss BG et al 48Vazquez C (abst) 563, 582Vázquez L (abst) 578Vázquez Martul M (abst) 560Veciana LL (abst) 573

Vécina F See Gris i-C et al 807Vega N (abst) 582Velasco IC (abst) 1738Véniant M, Heudes D, Clozel i-P, Bruneval P, Ménard

J: Calcium blockade versus ACE inhibition in clippedand unclipped kidneys of 2K-ic rats 421

Veninga A (abst) 1469Ventura RTP (abst) 1748Venturini AP See Gambaro G et al 797Verdijk MAJ (abst) 1467Verdijk MAJ See Knoers NVAM et al 170Verdouw PD (abst) 1460Vereerstraeten P See Abramowicz D et al 1596Vergara E (abst) 583Verhagen NAM (abst) 1460Verme D See Hebert LA et al 1688Verseput GH (abst) 1464Versolato C (abst) 1741Verweij CL (abst) 1468Vidau P (abst) 556, 571, 571Videen iS, Ross BD: Proton nuclear magnetic resonance

urinalysis: Coming of age 46:S-122Vieira JGH (abst) 1751Vijt D See Lameire N et a! 47:S-31Villafruela J (abst) 575Villafruela Ji (abst) 555, 555Villamil F See Recio F et al 46:S-89Villaverde M (abst) 579Vinzia C (abst) 557, 558, 573Virgili N (abst) 558Virgós Soriano MJ (abst) 587Virot iS (abst) 1247Visscher CA (abst) 1472Vitriá J See Moreso F et al 1721Vives L (abst) 554Viachojannis J See Kurz P et a! 855Vlahcevic ZR See Pandak WM et al 358Vogel M See Amling M et al 733Volk S See Wagner J et al 1542Voorhees JJ See Young EW et a! 1216Voswinckel P: A marvel of colors and ingredients. The

story of urine test strips 46:5-3

wWachter H See Fuchs D et a! 46:S-8Wada 0 See Yanagisawa H et a! 245Wada T, Yokoyama H, Tomosugi N, Hisada Y, Ohta S,

Naito T, Kobayashi K-i, Mukaida N, Matsushima K:Detection of urinary inter!eukin-8 in glomerulardiseases 455

WadaTSeeKimSetal 1346Wagner i, Drab M, Gehlen F, Langheinrich M, Volk S,

Ganten D, Ritz E: PCR analysis of human renalbiopsies—Renin gene regulation in glomerulonephritis... 1542

Wal Avd (abst) 1461Waldherr R (abst) 1744, 1745Walker AM (abst) 925, 942Walker R (abst) 922Walker RG (abst) 921Walker RJ (abst) 927, 929, 930, 935, 936Walker Ri See Corboy J et a! 1147Wall D (abst) 923Walter (abst) 939Walter M See Tepel M et a! 696Walton C See Gaber L et al 161

Author Inde,r: VoL 46 1789

Wang N-HL See Clark WR et al 1140Wang T-T, Chen M, Lachance S, Delalandre A, Carrière

S, Chan JSD: Isoproterenol and 8-bromo-cyclicadenosine monophosphate stimulate the expression ofthe angiotensinogen gene in opossum kidney cells 703

Wang Y See Schramek H et al 1644

Wapstra FH (abst) 1467Warren E (abst) 938Warren JW See Trifillis AL et a! 1083Watanabe M See Fukamizu A et a! 1533

Waugh DA (abst) 921, 923, 929, 933, 940, 940Weeks BS See Ray PE et al 759Weening JJ (abst) 1459, 1464Weening JJ See Kallenberg CGM et al 1Wei C-M See Mattingly MT et al 744Weimar W (abst) 1460Welch WJ See Deng X et al 639Wellard RM (abst) 931Wells JE (abst) 921Wener MH See Johnson RJ et al 1255Werle E See Boege F et al 46:S-93Werner BG See Pereira BJG et al 886Werner E See Kurz P et al 855Westberg G, Shultz PJ, Raij L: Exogenous nitric oxide

prevents endotoxin-induced glomerular thrombosis inrats 711

Westhuyzen J (abst) 923Wetzels JFM (abst) 1461, 1465White T See Newman DJ et al 46:S-20Whittier FC See Hebert LA et al 1688Whitworth CE, Fleming S, Cumming AD, Morton JJ,

Burns NJT, Williams BC, Mullins JJ: Spontaneousdevelopment of malignant phase hypertension intransgenic Ren-2 rats 1528

Wielbo D See Phillips MI et al 1554Wieslander J See Heilmark T et a! 823

Wigan M (abst) 923

Wigg N (abst) 928Wilcox CS See Deng X et al 639Wilcox CS See Mohaupt MG et al 653Wilkie M See Newman DJ et a! 46:S-20Wilkins GT (abst) 936Wilkinson JL (abst) 921Willekes-Koolschijn N See Joles JA et al 97Williams BC See Noble AR et a! 1588Williams BC See Whitworth CE et al 1528Williams GH: Genetic approaches to understanding the

pathophysiology of complex human traits 1550Williams JD See Coles GA et al 47:S-14Williams JD See Donovan KL et al 1431Williams JD See Gahl GM et al 47:S-1Williams JD See Martin J et al 877Williams JD See Topley N et al 47:S-71Williams JD See Topley N et a! 900Williams JD See Yung S et al 527Williams JM See Chini CCS et al 28Williams K See Andreoli SP et al 1100Wilison R See Johnson RJ et al 1255Willson R See Johnson RJ et al 1700Wilmink JM See Bemelman FJ et al 1674Wilson D (abst) 938, 940Wilson J (abst) 922Wilson J See Johnson RJ et al 1700

Wilson S (abst) 936Winearls C (abst) 921Wingard RL See Ikizler TA et a! 1178Witztum J (abst) 926Wolf G See Scherberich JE et al 46:S-52

Wong KC (abst) 923, 929, 933Wong KM (abst) 925Wood CJ (abst) 929Woodroffe AJ (abst) 940Woolfson RG, Poston L, de Wardener HE: Digoxin-like

inhibitors of active sodium transport and bloodpressure: The current status (Editorial Review) 297

Wrenger E See Brunkhorst R et a! 47:S-25Wright CE See Pereira BJG et al 886Wright JW See Harding JW et al 1510Wright TL See Pereira BJG et al 886

Wyburn KRL (abst) 926

YYamabe H See Johnson RJ et al 1255Yamano Y See Chaki S et al 1492Yan Y See Catanzaro DF et al 1513

Yanagisawa H, Kurihara N, Klahr 5, Morrissey J, Wada0: Dietary protein restriction in isolated glomerulifrom rats with bilateral ureteral obstruction 245

Yandle TG (abst) 934Yano Y (abst) 1742Yaqoob M, McClelland P, Patrick AW, Stevenson A,

Mason H, Bell GM: Tubulopathy withmacroalbuminuria due to diabetic nephropathy andprimary glomerulonephritis 46:S-101

Yates NA (abst) 934Yokoo M (abst) 1745Yokoyama H See Wada T et al 455

Yong SL (abst) 1468Yoon SJ See Ha H et al 1620Yoshida F See Matsuo S et a! 191

Yoshida H, Kakuchi J, Yoshikawa N, Saruta T, InagamiT, Phillips J, Ichikawa I: Angiotensin II type 1receptor gene abnormality in a patient with Bartter'ssyndrome 1505

Yoshikawa N See Nakanishi K et al 1413Yoshikawa N See Yoshida H et al 1505Yoshioka K See Ichida S et al 89Yoshioka K See Nakanishi K et al 1413Yoshioka K See Nakazato H et al 1307Yoshioka T, Homma T, Meyrick B, Takeda M, Moore-

Jarrett T, Kon V, Ichikawa I: Oxidants inducetranscriptional activation of manganese superoxidedismutase in glomerular cells 405

Young EW, Ellis CN, Messana JM, Johnson KJ,Leichtman AB, Mihatsch MJ, Hamilton TA, GroisserDS, Fradin MS, Voorhees JJ: A prospective study ofrenal structure and function in psoriasis patientstreated with cyclosporin 1216

Young EW See Hsu CH et al 605Yu L (abst) 1747Yuan Z-Y, Rodela H, Hay JB, Oreopoulos DG,

Johnston MG: Effect of phosphatidylcholine onlymphatic drainage and fluid loss from the peritonealcavity of sheep 520

Yukimura T See Kim S et al 1346


Yung 5, Coles GA, Williams JD, Davies M: The sourceand possible significance of hyaluronan in theperitoneal cavity 527

Yusa N See Fiotta 0 et al 46:5-117Yuzawa Y See Ichida S et al 89Yvert J-P See Maniar S et al 1705

zZacharias U See Nguyen 0 et al 208Zager RA: Acute renal failure in the setting of bone

marrow transplantation (Nephrology Forum) 1443Zagury A (abst) 1747Zamorano A (abst) 558Zemel D, Imholz ALT, de Waart DR, Dinkla C, Struijk

DO, Krediet RT: Appearance of tumor necrosisfactor-a and soluble TNF-receptors I and II inperitoneal effluent of CAPD 1422

Zeng T See Sernia C et al 1574Zerbini G See Pontremoli R et al 365Zerdlinger SC See Cohen MAH et a! 1375

Zhang GY (abst) 940Zhang PL, Mackenzie HS, Troy JL, Brenner BM: Effects

of natriuretic peptide receptor inhibition on remantkidney function in rats 414

Zhao J, Ardaillou N, Lu C-Y, Placier 5, Pham P, BadreL, Cambar J, Ardaillou R: Characterization of C-typenatriuretic peptide receptors in human mesangial cells.. 717

Zhu MO (abst) 1462Zhu Z See Tepel M et al 696Zhuo J, Alcorn D, McCausland J, Mendelsohn FAO:

Localization and regulation of angiotensin II receptorsin renomedullary interstitial cells 1483

Zidek W See Tepel M et a! 696Zietse R (abst) 1460Zingraff J (abst) 1244, 1244Zitouni Z (abst) 1244Zondervan K (abst) 1462Zugaib M (abst) 1748Zuliani C (abst) 1745Zwaginga JJ (abst) 1469

Date post:	20-Aug-2020
Category:	Documents
Upload:	others
View:	2 times
Download:	0 times

Author Index For Volume 46 - COnnecting REpositories · Barker CV See Julian BA et al 1397...

Documents